COMMON REFERENCE RANGE VALUES[\*](#fn1){ref-type="fn"} {#cesec1}
======================================================

 

SAMPLE HANDLING {#cesec2}
===============

SAMPLE IDENTIFICATION {#cesec3}
---------------------

Identification of specimens is critical if the right result on a given patient is to get back to the right clinician in a timely manner. The following steps are recommended:1.Write the animal/client name on *each* specimen container.2.Write the animal and client name, species, breed, gender, and date on the test requisition form.3.Make sure that the originating clinic name and account number are clearly identified on the form.4.Clearly mark or write down the needed tests on the form. (NOTE: Commercial laboratories receive hundreds of samples each day with no test marked!)5.Indicate the source, if other than a blood sample, on the form.6.Identify the tissue or fluid source and clinic ID on all slides submitted for cytology (use a lead pencil to write on the frosted side).

SAMPLE COLLECTION TUBES {#cesec4}
-----------------------

Most practices utilize a variety of **glass** vacuum tubes (Vacutainer)[†](#fn2){ref-type="fn"} to collect and submit blood, serum, or plasma from individual patients. The tubes are actually designed for collecting blood samples from humans. A variety of tube sizes, each of which maintains a pre-determined negative pressure (vacuum) inside, are available. The vacuum facilitates collection of an appropriate volume of the patient\'s blood to nearly fill the tube. Additionally, most of the blood collection tubes contain an additive that will either accelerate or prevent clot formation.

Adult (human) tubes are available in 5-mL, 7-mL, 10-mL, and 15-mL sizes. Pediatric (human) tubes, appropriate for use in companion animal patients, are available in 2-mL, 3-mL, and 4-mL sizes. For tubes containing an additive, filling the tube with an appropriate volume of blood is important. *Underfilling* any tube that contains an additive may sufficiently alter the sample such that the test results are adversely affected and may not accurately represent the patient\'s status.

The color of the stopper in the top of the tube indicates the type of additive, if any, and the specific type of tests that can be performed with that sample. For example, do not send serum when plasma is required!

Reference range values listed for [TABLE 5-1](#cetable1){ref-type="table"}, [TABLE 5-2](#cetable2){ref-type="table"}, [TABLE 5-3](#cetable3){ref-type="table"}, [TABLE 5-4](#cetable4){ref-type="table"}, [TABLE 5-5](#cetable5){ref-type="table"} are representative values only and will vary among individual laboratories.TABLE 5-1Hematology Reference Range ValuesTestAdult canineAdult felineUnitsRed Blood Cell (total)5.32--7.756.68--11.8×10^6^ cells/mm^3^Hemoglobin (Hgb)13.5--19.511.0--15.8gramsHematocrit (Hct)39.4--56.233.6--50.2%Mean Corpuscular Volume (MCV)65.7--75.742.6--55.5fLMean Corpuscular Hemoglobin (MCH)22.57--27.013.4--18.6pgMean Corpuscular Hemoglobin34.3--36.031.3--33.5g/dLConcentration (MCHC)Platelet Count194--419198--405×10^3^ cells/mm^3^Mean Platelet Volume (MPV)8.8--14.311.3--21.3fLWhite Blood Cell (Total)4.36--14.84.79--12.52×10^3^ cells/mm^3^Segmented Neutrophils (Segs)3.4--9.81.6--15.6×10^3^ cells/mm^3^Non-Segmented Neutrophils (Bands or Non-Segs)0--0.010--0.01×10^3^ cells/mm^3^Lymphocytes (Lymphs)0.8--3.51.0--7.4×10^3^ cells/mm^3^Monocytes (Monos)0.2--1.10--0.7×10^3^ cells/mm^3^Eosinophils (Eos)0--1.90.1--2.3×10^3^ cells/mm^3^Basophils (Basos)00×10^3^ cells/mm^3^TABLE 5-2Biochemistry Reference Range ValuesTestAdult canineAdult felineUnitsGlucose73--11663--150mg/dLBlood Urea Nitrogen (BUN)8--2715--35mg/dLCreatinine (Cr)0.5--1.60.5--2.3mg/dLPhosphorus (P)2.0--6.72.7--7.6mg/dLCalcium (Ca)9.2--11.67.5--11.5mg/dLIonized Calcium (iCa)1.15--1.39---mg/dLTotal Protein (TP)5.5--7.25.4--8.9g/dLAlbumin (Alb)2.8--4.03.0--4.2g/dLGlobulin (Glob)2.0--4.12.8--5.3g/dLCholesterol (Ch)138--31742--265mg/dLBilirubin (Total)0--0.20.1--0.5mg/dLAlkaline Phosphatase (SAP or Alk Phos)15--1460--96IU/LAlanine Aminotransferase (ALT)16--735--134IU/LGamma Glutamyltransferase (GGT)3--80--10IU/LCreatine Kinase (CK; formerly CPK))48--38072--481IU/LSodium (Na)147--154147--165mEq/LPotassium (K)3.9--5.23.3--5.7mEq/LA:G ratio0.6--2.00.4--1.5---Na/K ratio27.4--38.430--43---Chloride (Cl)104--117113--122mEq/LBicarbonate (Venous)20--2922--24mEq/LAnion Gap16.3--28.615--32---Osmolality (Calculated)292--310290--320mOsm/kgAmylase347--1104489--2100IU/LLipase22--2160--222IU/LTriglyceride (TG)19--13324--206mg/dLTABLE 5-3Urinalysis (Voided Sample) Reference Range ValuesTestCanineFelineSpecific Gravity (SpGr)variablevariableColorpale to dark yellowpale to dark yellowpH5.0 to 8.55.0 to 8.5Proteinnegative to + 1negative to + 1GlucosenegativenegativeKetonesnegativenegativeBilirubinnegative to tracenegativeBloodnegativenegative***Microscopic:***Red Blood Cell (RBC) Count\<5 RBCs/hpf\<5 RBCs/hpfWhite Blood Cell (WBC) Count\<3 WBCs/hpf\<3 WBCs/hpfEpithelial CellsnegativenegativeCastsnegativenegativeBacterianegativenegativeSpecial: Urine Protein:Creatinine\<0.3\<0.6TABLE 5-4Hemostasis Reference Range ValuesTestCanineFelinePlatelet Count166--600 × 10^3^/μL230--680 ×10^3^/μLProthrombin Time (PT)5.1--7.9 sec8.4--10.8 secActivated Partial Thromboplastin Time (APTT)8.6--12.9 sec13.7--30.2 secFibrin Degradation Products (FDP)\<10 μg/mL\<10 μg/mLFibrinogen100--245 mg/dL110--370 mg/dLActivated Clotting Time (ACT)60--110 sec50--75 secTABLE 5-5Blood Gas Analysis---Arterial Reference Range ValuesTestCanineFelineUnitspH7.36--7.447.36--7.44-PO~2~90--10090--100mmHgPCO~2~36--4428--32mmHgHCO~3~^−^24--2620--22mEq/LTCO~2~25--2721--23mEq/L

**Note:** Most commercial laboratories recommend collecting a minimum volume of 2.0 whole blood for routine biochemical analyses; 2.0 mL of whole blood will yield close to 1.0 mL of serum. Dehydrated patients are expected to have a higher hematocrit, and therefore a larger volume of whole blood may be required in order to obtain a 1.0-mL sample of serum.

**Note:** When collecting blood from a patient, it is critical to use:1.The appropriate sized tubes2.Tubes that contain the proper additive for the test(s) being requested

Types of commercial blood collection tubes used in veterinary medicine are discussed in [TABLE 5-6](#cetable6){ref-type="table"}, [TABLE 5-7](#cetable7){ref-type="table"}, [TABLE 5-8](#cetable8){ref-type="table"}, [TABLE 5-9](#cetable9){ref-type="table"}, [TABLE 5-10](#cetable10){ref-type="table"}, [TABLE 5-11](#cetable11){ref-type="table"}, [TABLE 5-12](#cetable12){ref-type="table"}, [TABLE 5-13](#cetable13){ref-type="table"}, [TABLE 5-14](#cetable14){ref-type="table"} . Interpretation of the in-office coagulation screen is discussed in [Table 5-15](#cetable15){ref-type="table"} .TABLE 5-6Red-Topped Tube**Additive**None**Effect**Allows blood to clot naturally; centrifugation is required to separate serum**Tests**Routine biochemistry, serology; cross-match; most liquid samples collected by centesis or aspiration for biochemistry or cytopathology--- e.g., CSF, abdominal fluidTABLE 5-7Red and Gray Mottled Top ("Tiger-Topped Tube"); Also Called Serum Separator Tube (SST)**Additive**Serum separator gel with clot activator**Effect**Gel at the bottom of tube acts to separate cells (lower fraction) and serum (upper fraction); sample should be centrifuged to stabilize**Tests**Routine biochemistry, serologyTABLE 5-8Lavender-Topped Tube; Also Called "Purple-Topped Tube"**Additive**EDTA (liquid)**Effect**Anticoagulant; removes calcium**Tests**Routine hematology; cross-match. NOTE: Invert eight times to prevent clotting and platelet clumpingTABLE 5-9Dark Green-Topped Tube**Additive**Sodium heparin or lithium heparin**Effect**Anticoagulant; inactivates thrombin and thromboplastin, allowing isolation of plasma; sample must be centrifuged to isolate plasma**Tests**Ammonia, lactate, and other tests requiring plasma (see under **Sample** and **Submit** for individual tests listed in this section)TABLE 5-10Light Blue-Topped Tube**Additive**Sodium citrate**Effect**Anticoagulant; removes calcium; NOTE: EDTA anticoagulated samples do NOT substitute for samples requiring citrated plasma**Tests**Most coagulation profiles; NOTE: Tube must be filled to the capacity allowed by the vacuumTABLE 5-11Dark Blue-Topped Tube**Additive**Sodium heparin or Na EDTA**Effect**Anticoagulant; tube is designed to contain no contaminating metals**Tests**Toxicology and trace element testing (e.g., zinc, copper, lead, mercury) and certain drug level testing (consult with laboratory prior to submitting)TABLE 5-12Gray-Topped Tube**Additive**Sodium fluoride and potassium oxalate**Effect**Antiglycolytic agent that serves to preserve glucose for up to 5 days**Tests**Glucose and 12- hour glucose curves; NOTE: Inadequate volume may result in sample hemolysisTABLE 5-13Yellow-Topped Tube**Additive**Acid-Citrate-Dextrose (ACD)**Effect**Inactivates complement**Tests**DNA testingTABLE 5-14Brown-Topped Tube**Additive**Sodium heparin**Effect**Inactivates thrombin and thromboplastin**Tests**Lead determination (consult with individual laboratory regarding alternative handling)TABLE 5-15Interpretation of the In-Office (or Point-of-Care) Coagulation ScreenPlatelet (estimate)LowThrombocytopeniaACTRapid, prolongedIntrinsic or common clotting pathway defectAPTTRapid, prolongedIntrinsic or common clotting pathway defectBMBTProlongedThrombocytopenia, thrombocytopathia

SAMPLE STORAGE AND TRANSPORT {#cesec5}
----------------------------

Several types of sample collection/sample submission storage tubes are available. It is critical that the type of blood collection and/or storage tube used meets the requirements of the test as defined by the laboratory.

To prepare a sample for storage and transport:1.Stabilize serum from serum separator tubes (SSTs) by centrifuging the specimen before submission. If being mailed, it is preferable to transfer the separated serum to a labeled plain red-topped tube (RTT).**Note:** Depending on the test requested, the tube used to *COLLECT* the sample is frequently *NOT* the same tube used to *SUBMIT* the sample. Sample collection and sample submission requirements are provided for ALL tests listed in this section.2.Centrifuge the blood samples in a plain RTT and transfer the serum to another RTT.3.Refrigerate and transport all blood specimens, cytology fluids, tissues, viral cultures, and urines for urinalysis or culture with ice packs.4.Keep all routine microbial cultures (except urine) and blood cultures at room temperature.5.If a specimen must remain frozen for transport, dry ice is required. It is usually the responsibility of the individual practice to package frozen samples correctly. Most laboratories do not provide dry ice for shipping.

PATIENT PREPARATION {#cesec6}
-------------------

Fasting the patient for 8-12 hours (an overnight fast with free access to water) is often helpful to reduce the likelihood of lipemia, which may interfere with several tests by falsely increasing or decreasing the results. When applicable, comments about the presence and influence of lipemia and/or hemolysis should appear on the laboratory reports. For special tests, patient preparation may include restriction of food *as well as* water and certain drugs. It is important to follow the guidance provided in this section regarding patient preparation or to contact the laboratory for specific instructions.

MINIMIZING HEMOLYSIS {#cesec7}
--------------------

Hemolysis during blood drawing can be minimized by adhering to the following recommendations.

Procure a nonlipemic (fasted) sample, because lipemia can increase red cell fragility. During phlebotomy, negative pressure created by the vacuum tube or syringe may collapse the lumen of the vein against the needle, thereby crushing numerous red cells. The flutter of the lumen against the needle can be stopped by reducing the negative pressure exerted during collection and by repositioning the needle with slight rotation or deeper insertion.

Excessive negative pressure exerted as the blood enters the vacuum tube or syringe can create hemolysis. This occurs during a slow or difficult collection, because the natural tendency is to use more negative force to enhance blood flow. More patience and "milking" the vein by alternating gentle negative pressure with a short release of all pressure usually solves the problem.

Hemolysis often occurs during the transfer of blood from a syringe into vacuum or other tubes. If a small-gauge needle is used, transfer of blood to specimen tubes is slowed, especially if small clots are present. Forcing the blood through a small-bore needle contributes to hemolysis. This problem can be avoided by removing the needle and top of the specimen tube, and transferring the blood directly into the open tube. Recapping the tube and aspirating a small amount of air to reestablish negative pressure helps to avoid having caps coming off in transit.

AVOIDING CLOTS AND PLATELET CLUMPS {#cesec8}
----------------------------------

The presence of clots and clumped platelets in anticoagulated blood is most commonly caused by a slow blood draw and the resulting delay in mixing it with the appropriate anticoagulant. If the venipuncture was traumatic, tissue fluid (thromboplastin), activated clotting factors, and hemolysis will quickly promote clot formation. The slight transfer delay when using a syringe for collection can also contribute to this problem. To avoid the formation of clots:1.Select a vein with good blood flow---the larger the better.2.Minimize the trauma of venipuncture.3.Collect blood directly into anticoagulated vacuum tubes (e.g., blue-topped tube \[citrated\] or lavender-topped tube \[EDTA\]).4.Mix the tube well by inverting several times *immediately* after filling.

If the syringe method is selected and a difficult draw is anticipated, the potential for clotting can be minimized by first rinsing the needle and syringe with a small quantity of liquid citrate (blue-topped tube) or EDTA (lavender-topped tube). However, the anticoagulant must be emptied from the syringe before proceeding, and care must be taken to match the anticoagulant chosen with the tests to be performed. Even trace amounts of heparin or EDTA will invalidate coagulation testing, whereas EDTA or citrate will alter the accuracy of several chemistry assays. A small amount of heparin contamination is acceptable in most chemistry assays and complete blood count parameters.

Platelet clumping in samples from cats is very common and is caused by contact aggregation. An effective method to prevent this clumping has not been found. Applying fresh blood directly to the slide from the syringe and making the blood smear immediately after collection is an effective method of assessing platelet numbers in cats.

SUBMISSION REQUIREMENTS FOR RABIES SUSPECTS {#cesec9}
===========================================

Guidelines for submitting tissue from dead dogs or cats for rabies diagnostic testing vary somewhat from state to state. It is always important to contact your State Veterinary Diagnostic Laboratory or Dept of Public Health *prior to shipping any* samples. Most public health authorities require advance notification about impending submission of samples for rabies testing. Veterinarians should verify the address, paper work requirements and shipping requirements prior to submitting any samples for rabies testing.

**Note: CAUTION**: Care must be taken during sample preparation to avoid direct personal contact with specimens. Pre-exposure rabies vaccination is recommended for persons preparing rabies specimens.

SAMPLE SUBMISSION FOR RABIES TESTING {#cesec10}
------------------------------------

1.Laboratories may limit acceptance of tissue from dead animals for rabies testing to those for which there is a documented reason for considering that animal a **rabies-suspect mammal**. Generally this includes animals for which there has been a **reported bite, scratch, or other possible saliva or nervous tissue exposure to a human.**2.Most laboratories will accept any bat as long as there is reasonable likelihood that a human was exposed.3.Brain tissue from a rabies-suspect mammal reported to have bitten (or otherwise had "intimate" contact with) a domestic animal will likely be acceptable (e.g., brain tissue from a stray dog or cat that bit a pet dog or cat)**.**4.**Highly suspect surveillance specimens** (with no reported contacts) includea.A rabies vector species (e.g., skunk or raccoon) showing clear signs of rabies infectionb.A mammal **not commonly recognized as a rabies vector, but showing clear signs of rabies infection**c.A domestic animal that dies or is euthanized under the care of a veterinarian for which rabies is **part of the differential diagnosis of a neurologic disorder.**5.Most laboratories will not accept live animals as rabies suspects. The intact head only of authorized specimens will be accepted. Exceptions include bats, which should be submitted whole, and livestock, for which a cross-section of the brainstem and representative sections of brain (as defined by the laboratory) may be removed by a veterinarian and submitted. Special livestock instructions may apply.

PACKAGING REQUIREMENTS FOR AUTHORIZED SAMPLES {#cesec11}
---------------------------------------------

In the case of a suspect dog or cat, the entire brain must be properly packaged in a standard rabies shipping container (these are often provided at County Health Departments). Specimens must be accompanied by a completed **rabies specimen history form.** Forms can often be downloaded from a website designated by the State Public Health authorities or the diagnostic laboratory.

INFORMATION REQUESTED ON THE RABIES SPECIMEN HISTORY FORM {#cesec12}
---------------------------------------------------------

1.Name and address of veterinarian submitting the specimen.2.Name and address of owner (if known).3.Indicate whether or not human exposure occurred and the type of exposure (e.g., bite, scratch). Also note whether exposure to a rabid animal is known or highly suspect.4.Specimen:a.Type of specimen.b.Age/breed/gender/pet versus stray versus wildlife.c.Cause of death (euthanasia, killed, natural causes).d.Medical history of the animal (if known), including date of last rabies inoculation.e.Health status of the animal at the time of death.5.Location: describe the geographic location (exact address) of the animal when the specimen was collected.

SUBMISSION GUIDELINES {#cesec13}
---------------------

1.Diagnostic testing of the specimen is generally performed by a designated laboratory within the state. Prior authorization to submit a rabies-suspect specimen is generally required; it is always recommended.2.If the submission is an emergency, or made over a weekend/holiday, most laboratories will provide specific instructions to accommodate a veterinarian\'s request.3.Do not submit live animals.4.If the suspect animal is alive, it should be humanely euthanized without damaging the head. The head must then be removed from the body and submitted intact for examination. Brain tissue that is damaged may not be accepted by the laboratory. Dead suspect bats can usually be submitted with the head intact.5.Specimens must be preserved by refrigeration. Freezing should be avoided. Only if refrigeration is not available can the tissue be submitted frozen.6.Tissues must not be fixed with chemical preservatives.7.Tools, cages, and other surfaces potentially contaminated with infectious saliva or blood can be disinfected with a solution of sodium hypochlorite (1 part household bleach to 10 parts water) in water.8.Properly packaged specimens may be shipped directly to the rabies laboratory (verify correct address) by parcel post or commercial mail carrier. Special arrangements are likely to be required for samples arriving over weekends or holidays.

PACKING AND SHIPPING DIRECTIONS {#cesec14}
-------------------------------

An acceptable rabies suspect shipping set may include any of the following:1.One pre-assembled shipping container, including outer cardboard box, insulated cooler, and two gallon-sized cans with lid-locking plastic seal. Packing instructions for package are printed on top inner flaps.2.Two gel packs of refrigerant (store the pack---*not the specimen*---frozen until needed).3.Two plastic bags (13 × 20 inches × 4 mil) in which the animal head, brain of livestock or other large animal, or intact bat is to be sealed before placing in can.4.Two plastic bags (13 × 20 inches × 4 mil) in which to place the cans.5.One large plastic bag that surrounds the closed insulated cooler.6.Two absorbent pads to be placed in the cans, surrounding the specimen.7.Two blank rabies history forms and directions for collection and submission of specimens.

To prepare the specimen for shipping:1.Remove the head from the body of the animal (except bats) and place the head in a small plastic bag. Cool specimen in a refrigerator or freezer before packaging, to enhance preservation.2.When shipping samples consisting of only cerebellum and brainstem, first place the brain tissue in a small plastic container, then place the container in the small plastic bag. If sharp objects protrude from the specimen (e.g., bone fragments, porcupine quills) wrap specimen in several layers of newspaper before putting head in the plastic bag. Wrap bagged specimen in provided absorbent material and place inside the metal can.3.Place the lid on the metal can and secure with a mallet. Place a plastic pressure ring (provided) on the can and secure with a mallet. The plastic ring will be seated more easily if a hard surface is placed on top of the ring before using the mallet. This will allow even pressure to be applied to the ring. **CAUTION! Infectious splashes can occur when hammering the lid in place if the groove is contaminated with blood or body fluids in the specimen.**4.Wash hands well with soap and water. Disinfect or burn all materials contaminated in specimen preparation.5.Complete the rabies specimen history form provided with the package. Answer all questions as accurately as possible; the history form will be used to report results to the local health authority. Place form on the outside of the plastic bag that surrounds the EPS cooler. When shipping more than one specimen in the container (e.g., bats), be certain that: **each** specimen is individually bagged to prevent cross contamination; **each** is clearly identified, and a separate history included for **each** specimen.6.CAUTION: Do not use glass, wire, or other packaging materials capable of causing wounds or injuring skin.

HISTOPATHOLOGY AND CYTOPATHOLOGY {#cesec15}
================================

Histopathology and cytopathology are among the most important diagnostic tools available for use in clinical practice. Generally, diagnostic specimens are submitted to a commercial laboratory or university where specially trained technologists can prepare and stain the cells/tissue to be interpreted by a pathologist. One critical limiting factor in obtaining diagnostic cytology or histopathology is the quality of the specimen submitted. *It is the responsibility of the practice to not only obtain, but also prepare, specimens properly before submission and interpretation.* This part of Section 5 describes standards for preparing and submitting specimens for cytologic or histopathologic interpretation. Sample collection techniques are described in Section 4.

HISTOPATHOLOGY {#cesec16}
--------------

### Biopsy Tissue {#cesec17}

Tissue specimens for histology must be preserved and transported in formalin (10 parts formalin to 1 part tissue). The ideal tissue specimen is less than an inch thick. OSHA and transportation safety regulations limit the size and quantity of formalin containers that can be shipped. It is strongly recommended to use containers supplied by the laboratory or the FAA-approved airline, place the container in a ziplock plastic bag, and then in a second outer bag that contains the requisition. Samples packaged inappropriately may not be picked up by the courier. **CAUTION:** Do not enclose cytology samples in bags containing formalin-fixed tissues because this may alter the cytologic appearance and staining of the cells of interest.

### Very Large Specimens {#cesec18}

Several (preferably three or more) representative sections of large tissues or organs should be selected, preserved, and transported for histology. The remainder should be placed in a large plastic container of formalin, refrigerated, and retained in case additional samples are needed.

### Tissue Orientation and Information {#cesec19}

Knowing the orientation and other facts about the tissue mass is critical for the pathologist. A diagram may be included on the requisition form. Borders and areas of interest on the mass can be marked with colored or numbered sutures. State whether the entire mass has been excised, if all is being submitted, or if the tissue had to be divided into sections before submission.

### Very Small Specimens {#cesec20}

Tiny samples, such as endoscopic biopsy specimens, are best preserved if they are first placed in a labeled tissue cassette holder (usually available from the laboratory) and then dropped into formalin. Small biopsies should not be placed in a container with large tissue, because they are easily lost.

CYTOPATHOLOGY {#cesec21}
-------------

Used alone, as a diagnostic screening test for underlying disease, or used in conjunction with the surgical biopsy to facilitate rapid assessment of a potentially serious lesion, cytopathology is among the most fundamental and important diagnostic tools used in clinical practice. Cytopathology is not a clinical discipline restricted to the realm of board-certified clinical pathologists. Several continuing education short courses and laboratories on diagnostic cytopathology are offered at major conferences throughout the U.S. In addition, excellent textbooks, with abundant color plates, are available to facilitate cytologic interpretation of specimens collected from dogs and cats.

Cytologic preparations are perhaps most useful for distinguishing details between cell types (e.g., mesenchymal vs. epithelial) and cellular activity (e.g., inflammation vs. neoplasia). Detection of intracellular vs. extracellular organisms can provide immediate clues, without waiting for organisms to be cultured, about the nature of the disease. Noninflammatory lesions can generally be distinguished as benign or neoplastic (Box 5-1).

Although it is the responsibility of the individual clinician to understand personal limitations, there is one special advantage that the clinician does have over the pathologist---familiarity with the patient\'s health status and the nature of the lesion/disease under consideration. Described here are guidelines for *preparing and submitting* samples for cytologic interpretation (see Section 4 for sample collection techniques). Whether samples are sent to a commercial laboratory or a university, or are interpreted within the practice, the following recommendations are important when preparing a high-quality specimen.

**Note:** The accuracy of interpreting cytopathologic specimens is dependent on four key variables:•Experience and training of the clinician•Selection of the appropriate case/lesion•Cellular quality of the specimen selected•Techniques used to collect, prepare, and stain the sample

### Fine Needle Aspiration (FNA) {#cesec22}

#### Indications {#cesec23}

FNA Involves the use of a syringe and needle to extract cells from a palpable lesion. Most commonly, FNA is performed on cutaneous and subcutaneous lesions. However, with the increasing use of ultrasound in private practice, it may not be necessary to actually "palpate" a lesion in order to extract diagnostic cytology (e.g., ultrasound-guided hepatic or splenic aspirates). Additional experience and training are essential when attempting to perform ultrasound-guided FNA.

#### Sample preparation {#cesec24}

Because sample size ("harvest") typically is small, the cells collected are discharged directly onto a dry, clean slide and allowed to *rapidly* (within 5 to 10 seconds) air-dry. It is recommended that the needle tip actually contact the slide as the aspirate is discharged *rather* than blowing the sample over the slide. If fluid is inadvertently recovered, the FNA should be reattempted from the peripheral limits of the lesion.

Extremely small harvest of cells can be sprayed directly on the slide, remain untouched, and allowed to air-dry. If the volume recovered allows placement of a formed drop onto the slide, the sample should be spread over the surface of the slide, prior to air-drying, in the same way that a peripheral blood smear is prepared.

#### Staining options {#cesec25}

Once the sample has air-dried (rapidly), use of a quick Romanowsky-type (Wright\'s) stain is appropriate. Alcohol fixation is *not* recommended if the specimen is to be reviewed/interpreted immediately. Alternative stains, such as new methylene blue (wet mount), Gram stain, Giemsa stain, or Wright-Giemsa stain, can be used in practice as dictated by cytologic objectives.

FNA specimens mailed to an outside laboratory typically are air-dried and left unstained. Some laboratories recommend that the specimen be immersed in methyl alcohol for a few minutes prior to sending, although this additional step seems to be optional.

#### Common mistakes {#cesec26}

Low cell harvest, high cellular density on the slide (e.g., the result of making a "bad" slide or failing to adequately disperse the sample), and obtaining nondiagnostic material are the three most common mistakes when obtaining samples for diagnostic cytopathology. Contamination of the "wet" (not yet air-dried) sample with water, alcohol, or stain can create artifacts that will compromise the diagnostic value of the specimen. Excessive blood or tissue fluids may profoundly dilute the diagnostic sample, making interpretation difficult or impossible.

### Exfoliative Cytology ("Impression Smear") {#cesec27}

#### Indications {#cesec28}

Exfoliative cytology is made from a clean surface of exposed lesions or from the surface of tissue collected during biopsy. Preparations made from the cut surface of fresh biopsy specimens or post-mortem tissues provide the greatest diagnostic yield.

#### Sample preparation {#cesec29}

To avoid one of the most common mistakes, excessive tissue fluid or blood is absorbed from the cut surface (using a scalpel blade) of the specimen before attempting to exfoliate cells on a slide. Clean, high-quality absorptive paper (such as filter paper) works well, and fragments of paper will not be left on the specimen.

Once excess fluid has been absorbed from the surface, the specimen is gently grasped and allowed to make *gentle* contact with a clean slide. The actual weight of the specimen is usually sufficient; it is usually not necessary to press the specimen onto the slide. After multiple contacts with the slide have been made, the sample is rapidly air-dried.

#### Staining options {#cesec30}

Once the sample has air-dried (rapidly), use of a quick Romanowsky-type (Wright\'s) stain is appropriate. Alcohol fixation is not recommended if the specimen is to be reviewed/interpreted immediately. Alternative stains, such as new methylene blue and Gram stain (wet mounts), Giemsa stain, or Wright-Giemsa stain, can be used in practice as dictated by cytologic objectives.

#### Common mistakes {#cesec31}

Excessive or rough handling of the specimen before attempting exfoliation will compromise the quality of the specimen. In addition, excessive blood or tissue fluid on the cut surface of the tissue may effectively "dilute" the diagnostic cells in the specimen, making interpretation difficult. When additional pressure is used to exfoliate cells or specimen is rubbed across the slide, individual cells are likely to rupture and smear, rendering the sample nondiagnostic. Failure to obtain adequate numbers of diagnostic cells is more likely to be the consequence of the type of tissue being examined than poor technique. Epithelial tissues (liver/spleen/adenoma/carcinoma) tend to exfoliate abundant numbers of cells when applied to a slide. In contrast, mesenchymal cell tissues (fibrosarcoma/chondrosarcoma) tend *not* to exfoliate well. Diagnostic yield of cells from mesenchymal tissue may be so low as to warrant submission of fixed tissue for histopathologic examination.

### Swabs, Scrapings, Washings, or Brushings {#cesec32}

#### Indications {#cesec33}

A variety of techniques are available to collect cytologic specimens from the upper and lower respiratory tract, conjunctiva, ear canals, and vaginal mucosa. In most cases, cytologic objectives focus on the recovery and identification of infectious organisms (mites, bacteria, etc). Section 4 describes the various techniques of sample collection from these locations.

#### Sample preparation {#cesec34}

Skin scrapings and ear swabs for diagnosis of infectious agents, and occasionally neoplasia, are perhaps the most common samples used in practice to collect diagnostic specimens. Gentle handling of the specimen once collected is the rule when attempting to exfoliate diagnostic cells or organisms. In addition, it may not be necessary to air-dry or apply a stain depending on the samples collected (e.g., skin scrapings or ear swabs for mites).

Samples collected from washings vary considerably in the cell harvest, the consistency of the fluid recovered, and the quality of the diagnostic specimen. In some cases, fluid recovered from washings (e.g., bronchoalveolar lavage, transtracheal aspiration) will require centrifugation to acquire sufficient numbers of diagnostic cells. The supernatant (fluid portion) of the sample is discarded. The cells recovered may be re-suspended in 1 or 2 drops of sterile saline or a volume of saline equal to the volume of specimen remaining in the centrifuge tube. A pipette is used to apply a sample of the fluid to a slide. The sample is distributed over the slide in the same way that a peripheral blood smear is prepared. The slide is air-dried and stained. In other cases, the sample collected from cytologic washings will be highly cellular and may be applied directly to a slide, air-dried, and stained.

Samples collected from brushings normally are obtained with specially made cytology brushes designed for use during endoscopy. Although small "pinch" biopsies are preferred, occasionally the use of a brush may be the only practical option. Cytologic specimens collected by brushing tend to be especially low in yield. Furthermore, the additional manipulation required to extract cells from the brush and onto a slide for examination tends to yield specimens of poorer quality. Cells obtained during brushing may be applied directly to a clean slide, air-dried, and stained. In other cases, it may be preferable to wash the brush in a centrifuge tube containing a small volume (\<1.0 mL) of sterile saline. The suspended cells may be applied directly to a slide, distributed, and then air-dried and stained. It may be necessary to centrifuge the sample (as described for washings previously) before preparing the sample.

#### Staining options {#cesec35}

Generally, the same staining options previously described apply to specimens collected from washings or brushings. Samples collected from skin scrapings typically are suspended in oil or hydrogen peroxide on the slide and examined "wet" without the use of additional stain. Swabs, especially from ears, may be stained with a quick Romanowsky-type stain or a Gram stain (wet mount) to facilitate identification of organisms.

#### Common mistakes {#cesec36}

Samples collected from skin scrapings and swabs tend to be relatively high in yield when diagnostic cells or organisms are present. Cells collected from washings and brushings are usually collected during endoscopic procedures; the yield of diagnostic cells can vary, depending on the extent of the lesion as well as the skill of the individual performing the procedure.

### Body Fluids {#cesec37}

#### Indications {#cesec38}

The accumulation of fluid in either the pleural space or the abdomen, or in both, justifies attempts to remove fluid for diagnostic cytology. The volume of sample can be difficult to determine, but ideally would be 2-3 mL of fluid collected by needle and syringe (centesis) under sterile conditions. Smaller samples of joint fluid and CSF are also collected for chemical and cytologic analysis. Any fluid recovered should be examined for color, consistency, total nucleated cell count, and protein concentration as well as for morphology of the cells recovered. Other chemistries (creatinine, amylase, etc.) can be determined depending on the nature of the fluid recovered and the patient\'s condition.

#### Sample preparation {#cesec39}

Because the volume of fluid obtained may be large and the concentration of cells in the fluid recovered may be low, centrifugation is indicated to concentrate cells in small aliquots of fluid. After centrifugation and removal of the supernatant, cells can be resuspended in 1-2 drops of sterile saline/supernatant. Suspended cells should be distributed directly on a slide, allowed to air-dry, and stained.

**Note:** It is important not to delay processing of cytologic samples recovered from body fluid. The longer cells are allowed to remain in suspension, the greater is the opportunity for morphologic changes of cells to occur.

Spinal fluid must be processed within 30 minutes of collection because of the fragility of cells in CSF. Furthermore, conventional centrifuges may damage any cells collected. Because of the complexities associated with processing of CSF for cytopathology, most samples are evaluated within specialty or referral hospitals.

#### Staining options {#cesec40}

Air-dried cytologic preparations can be stained in the same manner described previously.

#### Common mistakes {#cesec41}

Attempting to evaluate uncentrifuged cytologic specimens collected from body fluids can result in a low yield of diagnostic cells and may compromise the study. Allowing the cells to remain in the fluid for an extended period of time before making the cytologic preparations may significantly alter the morphology of individual cells, making interpretation difficult or impossible. Furthermore, the presence of peripheral blood in any sample collected from a body cavity must be distinguished from contamination associated with the sampling technique versus a primary bleeding disorder.

### Bone Marrow {#cesec42}

#### Indications {#cesec43}

Cytologic examination of a bone marrow aspirate is an especially valuable tool in the assessment of patients with persistent anemia, particularly nonregenerative anemia, abnormal numbers (either high or low) of leukocytes, thrombocytopenia, any blood dyscrasia detected in peripheral blood, and any combination of these findings. Bone marrow specimens will yield the most information if *both* a core biopsy and aspirate slides are submitted. The biopsy should be cut first, and the core placed in a tissue-processing cassette, labeled, and dropped into a formalin container. The aspirate needle can then be placed into the same puncture site as the biopsy needle. (Bone marrow biopsy and aspiration collection techniques are described in Section 4.)

Thrombocytopenia is *not* necessarily a contraindication to performing bone marrow aspiration. Assuming normal platelet function, bone marrow aspiration is indicated even when platelet counts are extremely low (e.g., 5000 platelets/mm^3^). The author has observed persistent bleeding and large hematoma formation at the site of aspiration in dogs with platelets counts \<3000 platelets/mm^3^ in peripheral blood.

#### Sample preparation {#cesec44}

In most patients undergoing bone marrow aspiration, sufficient numbers of platelets will be present in the sample to justify routine use of an anticoagulant. *Before* collecting the sample, a few drops of 4% EDTA are placed in the center of a watch glass. The same 12-cc syringe used to draw the EDTA is used to collect the sample. This syringe will contain a small amount of EDTA. Collection of marrow is typically limited to 0.5 mL. Larger volumes may cause hemodilution of the sample, making interpretation difficult. On withdrawing the appropriate volume, the sample is *immediately* added directly to the EDTA and mixed thoroughly. A glass pipette can be used to transfer the aspirated marrow onto a clean, dry slide. Other techniques are described in Section 4. Using the same technique to distribute peripheral blood for a differential count will suffice. The sample is allowed to air-dry.

#### Staining options {#cesec45}

Bone marrow staining routinely entails use of a quick Romanowsky-type stain. Special staining, usually performed by a commercial or university laboratory, may be indicated when looking for the presence of iron stores or specific types of organisms.

#### Common mistakes {#cesec46}

If the bone marrow contains functional platelets, failing to quickly transfer the aspirate into the EDTA can result in clot formation. The presence of clots is likely to entrap diagnostic cells, making interpretation difficult or impossible. Hemodilution and an excessive volume of EDTA are also common mistakes that can compromise the quality of the smears. Other complications usually are caused by errors in the technique of making the slide. For example, failing to adequately distribute the sample across the slide can result in a unusually thick preparation. Bone marrow aspirates taken from the head of the humerus can become contaminated with joint fluid, making the sample completely unusable.

BIOCHEMISTRY---ROUTINE {#cesec47}
======================

The ability to obtain a comprehensive biochemical profile, and to do so quickly and inexpensively, has become a routine part of the clinical work-up for the companion animal patient. Clearly, the biochemistry profile greatly expands the clinician\'s ability to assess the patient presenting with a history of clinical illness. Additionally, it is now feasible to obtain a biochemical profile on seemingly healthy patients as part of a routine "wellness examination."

This section discusses those analytes offered by most clinical laboratories performing companion animal (dog and cat) biochemistry profiles. Although specific analytes included on panels vary among laboratories, any individual test not discussed here can probably be found in the following section entitled Special Diagnostic Tests and Test Protocols.

The following criteria are applicable to *all* samples in which blood/serum/plasma is collected for which a routine biochemisty profile or special laboratory test is requested.

ANALYTE OR TEST NAME (SYNONYMS) {#cesec48}
-------------------------------

The name of the individual chemical analyte being measured (e.g., alkaline phosphatase) is followed in parentheses by common abbreviations used by laboratories when reporting results (e.g., SAP or Alk Phos). In some cases the name of the test is presented rather than the actual chemical being tested for (e.g., ACTH stimulation, in which cortisol is the actual analyte measured).

NORMAL {#cesec49}
------

Representative reference range values for normal adult dogs and cats are listed with each analyte. In addition, [TABLE 5-1](#cetable1){ref-type="table"}, [TABLE 5-2](#cetable2){ref-type="table"}, [TABLE 5-3](#cetable3){ref-type="table"}, [TABLE 5-4](#cetable4){ref-type="table"}, [TABLE 5-5](#cetable5){ref-type="table"}, [TABLE 5-6](#cetable6){ref-type="table"} summarize reference ranges for dogs and cats.

**Note:** Reference range values listed throughout this section are for general reference *only*. Test results from individual patients *must be compared with the reference range values of* the laboratory that performs the test.

PATIENT PREPARATION {#cesec50}
-------------------

Any unique patient preparation parameters should be followed *before* collecting the sample. For routine biochemistry profiles, an 8- to 10-hour fasting period is recommended when feasible. When performing routine profiles on normal patients, it is preferable to collect samples in the morning. Owners are instructed to withhold food and water after midnight on the day the blood sample is to be collected.

COLLECT {#cesec51}
-------

This section stipulates the type and volume of sample to be collected, as well as the type of collection tube to be used. For routine biochemistry, collecting at least 2.0 mL of whole blood in a red-topped tube (or serum separator tube) is required to obtain the minimum 1.0 mL of serum required for sample analysis. Dehydrated patients have a higher hematocrit, and a larger volume of whole blood may be required to obtain 1.0 mL of serum.

SUBMIT {#cesec52}
------

This section stipulates the type and volume of sample that is to be submitted for analysis. Also, the type of vial/container in which the sample should be shipped is specified. Unless specified in the protocol, do not store or ship samples as whole blood; instead, separate whole blood from serum before shipping unless using an appropriate serum separator tube. Serum samples should be shipped in a sterile red-topped tube. Freezing of the sample is not required for routine biochemistry profiles.

INTERPRETATION {#cesec53}
--------------

Each analyte and test procedure is described separately.

INTERFERENCE {#cesec54}
------------

This section stipulates common interfering substances/factors and indicates, when known, if the interference will falsely elevate or lower test results. Samples that are lipemic, icteric, and/or hemolyzed may cause test interference with individual analyte assays, resulting in unreliable test results. Interference may be positive (false increased test results) or negative (false decreased test results). The degree and type of interference vary depending on the test methodology used. Most laboratories provide details in final reports pertaining to known or potential interfering factors.

PROTOCOL {#cesec55}
--------

If indicated, the protocol stipulates specific test procedures or shipping requirements necessary to obtain the most valid results. For routine biochemistry profiles, other than recommended fasting of the patient, no specific test protocol is indicated. For special laboratory diagnostic tests for which patient preparation is required or a defined protocol is available, a detailed description is provided.

ROUTINE DIAGNOSTIC TESTS {#cesec56}
========================

ALANINE AMINOTRANSFERASE (ALT; FORMERLY SGPT) {#cesec57}
---------------------------------------------

**Normal:**

16-73 IU/L (dog); 5-134 IU/L (cat).

**Interpretation:**

Used in the assessment of liver disease (*not a test of liver function*). Increased values indicate hepatocyte injury and leakage of intracellular enzymes, such as could occur in acute hepatitis, hepatic trauma, neoplasia (occasionally), and cirrhosis. Decreased values may be noted in end-stage liver disease.

ALBUMIN {#cesec58}
-------

**Normal:**

2.8-4.0 g/dL (dog); 3.0-4.2 g/dL (cat).

**Interpretation:**

Evaluated with total protein and globulin. This test is important in the assessment of hydration status, renal disease, gastrointestinal disease, liver function, and selected chronic infectious diseases. Increased values generally support dehydration; a commensurate increase in globulin and total protein should be expected. Decreased values suggest abnormal loss (gastrointestinal tract or renal) and decreased production (protein-restricted diet, malnutrition, liver disease). Values in healthy young dogs and cats (\<3 months of age) are normally lower than those in adult animals.

ALBUMIN/GLOBULIN RATIO (A:G) {#cesec59}
----------------------------

**Normal:**

0.6-2.0 (dog); 0.4-1.5 (cat).

**Interpretation:**

The A:G should NOT be interpreted without consideration of the concentration (g/dL) of both albumin and globulin. Further characterization of serum proteins can be obtained with serum protein electrophoresis. An increased A:G is considered to be clinically insignificant because it represents either elevated albumin and/or decreased globulin. Alternatively, a decreased A:G indicates either decreased albumin and/or increased globulin and may indicate renal or gastrointestinal loss of albumin, certain neoplasms, or chronic infections.

ALKALINE PHOSPHATASE (SAP OR ALK PHOS) {#cesec60}
--------------------------------------

**Normal:**

15-146 IU/L (dog); 0-96 IU/L (cat).

**Interpretation:**

This test is routinely used to assess obstructive liver and/or biliary tract disease *(not a test of liver function).* Increased values are normal in young dogs and cats (\<3 months of age) (reflecting bone growth). In adults, increased values may indicate biliary obstruction/cholestasis, hepatitis, hepatic lipidopathy, destructive bone lesions (osteosarcoma), hyperphosphatemia, and acute pancreatitis. NOTE: Corticosteroid therapy will induce SAP, causing significant elevations in the absence of cholestasis.

AMYLASE {#cesec61}
-------

**Normal:**

347-1104 IU/L (dog); 489-2100 IU/L (cat).

**Interpretation:**

Increased value indicates pancreatitis, especially in patients with evidence of vomiting and abdominal pain. Amylase clearance is dependent on normal renal function; patients with compromised renal function (chronic renal failure) are likely to have abnormally elevated amylase not associated with pancreatic disease. Pancreatic lipase immunoreactivity (PLI) may be helpful in assessing pancreatitis in dogs and cats (see under Special Diagnostic Tests and Test Protocols).

ANION GAP {#cesec62}
---------

**Normal:**

16.3-28.6 (dog); 12-24 (cat).

**Interpretation:**

The anion gap is a laboratory calculation (Na -- \[Cl + HCO~3~ ^−^\] = anion gap) used to assess quantities of unmeasured cations (Ca, Mg) and anions (proteins, sulfates, phosphates, and certain organic acids). A high anion gap suggests metabolic acidosis (ketoacidosis, lactic acidosis). Other causes of metabolic acidosis (e.g., renal tubular acidosis) may have a normal anion gap. Hypoalbuminemia is the most common cause of a low anion gap. Other causes include hypernatremia, certain gammopathies (myeloma), and severe hypercalcemia. There are numerous causes for false high and low anion gap results.

ASPARTATE AMINOTRANSFERASE (FORMERLY SGOT) {#cesec63}
------------------------------------------

Although sometimes reported in companion animal laboratory profiles, these values are NOT considered to have clinical significance in either the dog or cat.

BICARBONATE (HCO~3~^−^) {#cesec64}
-----------------------

**Normal:**

24-26 mEq/L (dog); 22-24 mEq/L (cat).

**Interpretation:**

Bicarbonate measurement usually is included as a component with of blood gas and/or electrolyte panel. Levels are increased with metabolic alkalosis (and with compensated respiratory acidosis) and decreased with metabolic acidosis (and with compensated respiratory alkalosis).

BILIRUBIN {#cesec65}
---------

**Normal:**

0-0.2 mg/dL (dog); 0.1-0.5 mg/dL (cat).

**Interpretation:**

Increased value (hyperbilirubinemia) may be associated with icterus or jaundice, reflects accumulation of bilirubin in serum, and may indicate intravascular hemolysis, compromised bile excretion, biliary tract obstruction (intrahepatic or extrahepatic), and primary hepatic disease affecting bile excretion.

BLOOD UREA NITROGEN (BUN) {#cesec66}
-------------------------

**Normal:**

8-27 mg/dL (dog); 15-35 mg/dL (cat).

**Interpretation:**

NOTE: abnormally elevated BUN (azotemia) does not define "uremia." Increased BUN indicates decreased renal clearance of nitrogenous waste (dehydration, renal failure, urinary tract obstruction). An elevated BUN is NOT indicative of renal disease unless interpreted in light of other parameters (e.g., urine specific gravity, serum creatinine, history of increased water consumption or increased urination). Decreased BUN indicates increased renal excretion of nitrogenous waste (diuresis) or decreased protein intake (malnutrition, low-protein diet) or decreased production (portosystemic shunt).

CALCIUM (CA) {#cesec67}
------------

**Normal:**

9.2-11.6 mg/dL (dog); 7.5-11.5 mg/dL (cat).

**Interpretation:**

WARNING: Levels ≤7 mg/dL dogs and cats may result in tetany; sustained levels \>12 mg/dL may cause renal damage subsequent to calcium deposition. Increased levels are associated with primary hyperparathyroidism, pseudohyperparathyroidism (paraneoplastic syndrome associated with neoplasia, especially lymphosarcoma and perianal carcinoma), metastatic bone disease or primary bone tumors, hypervitaminosis D (chronic), hyperthyroidism (in cats), Addison\'s disease (hypoadrenocorticism), and acromegaly. Hypercalcemia may be idiopathic in some animals. Decreased values are associated with any condition causing low total protein and albumin levels (most serum calcium is albumin-bound). Serum ionized calcium is indicated in assessing any patient with significant, unexplained hyper- or hypocalcemia. Other causes of decreased calcium include conditions causing elevated phosphorus levels (e.g., renal insufficiency, hypoparathyroidism), acute pancreatitis, intravenous fluid administration, renal tubular acidosis. See also Calcium, Ionized (iCa).

CHLORIDE (CL) {#cesec68}
-------------

**Normal:**

104-117 mEq/L (dog); 113-122 mEq/L (cat).

**Interpretation:**

Increased Cl is associated with dehydration as well as intravenous saline administration. Decreased Cl can be associated with overhydration, Addison\'s disease (hypoadrenocorticism), burns, metabolic alkalosis, syndrome of inappropriate secretion of ADH, and certain types of diuretic therapy.

CHOLESTEROL (CH) {#cesec69}
----------------

**Normal:**

138-317 mg/dL (dog); 42-265 mg/dL (cat).

**Interpretation:**

Increased CH (hypercholesterolemia) is most commonly found in hyperlipidemic patients and reflects extreme elevations of triglyceride rather than a primary underlying metabolic disorder affecting CH metabolism. In dogs, hypercholesterolemia is inconsistently associated with hypothyroidism and hyperadrenocorticism (Cushing\'s syndrome). Hypercholesterolemia has limited diagnostic significance. Decreased CH (hypocholesterolemia) has not been found to be of diagnostic significance in the dog and cat, but has been observed with hypoadrenocorticism.

CREATINE KINASE (CK; FORMERLY CPK) {#cesec70}
----------------------------------

**Normal:**

48-380 IU/L (dog); 72-481 IU/L (cat).

**Interpretation:**

Increased CK indicates increased skeletal muscle activity or destruction (myopathy or rhabdomyolysis), inflammation or infection (myositis), or widespread muscle trauma. No diagnostic significance has been associated with a decreased CK.

CREATININE (Cr) {#cesec71}
---------------

**Normal:**

0.5-1.6 mg/dL (dog); 0.5-2.3 mg/dL (cat).

**Interpretation:**

Increased Cr is an important indicator of glomerular filtration and occurs with renal insufficiency and urinary tract obstruction; shock, severe dehydration, and untreated congestive heart failure may result in increased Cr due to decreased renal blood flow. Rhabdomyolysis will also cause increased Cr. Pathologic causes of decreased Cr are uncommon but may occur in severe debilitation or disease causing extreme decreases in muscle mass. Cr is less influenced by diet than by BUN.

GAMMA GLUTAMYLTRANSFERASE (GGT; GAMMA GT \[gGT\]) {#cesec72}
-------------------------------------------------

**Normal:**

3-8 IU/L (dog); 0-10 IU/L (cat).

**Interpretation:**

Parameters causing increased and decreased GGT typically parallel alkaline phosphatase (SAP) in the presence of underlying liver pathology, especially cholestasis, but *not* in patients with destructive bone disease. GGT is commonly elevated in cirrhosis and (obstructive) hepatic/biliary tract disease. Extreme elevations of GGT have been associated with metastatic liver disease in humans; a similar association has not been reported in animals.

GLOBULIN {#cesec73}
--------

**Normal:**

2.0-4.1 g/dL (dog); 2.8-5.3 g/dL (cat).

**Interpretation:**

Globulin is a component of total protein that must be interpreted with albumin. Increased value (hyperglobulinemia) may reflect dehydration (albumin and total protein also increased), chronic inflammation, chronic infection, or myeloid neoplasia (albumin may be abnormally decreased). Serum protein electrophoresis is indicated to characterize the nature of the globulin increase. Decreased value (hypoglobulinemia) typically indicates decreased protein intake (low protein diet or malnutrition) or decreased globulin production (neoplasia).

GLUCOSE {#cesec74}
-------

**Normal:**

73-116 mg/dL (dog); 63-150 mg/dL (cat).

**Interpretation:**

Increased value (hyperglycemia) indicates decreased glucose metabolism (insulin deficiency or diabetes mellitus). NOTE: normal cats may experience transient "stress hyperglycemia" with values as high as 350 mg/dL (typically, glycosuria is absent). Decreased value (hypoglycemia) indicates excessive utilization of glucose (insulin secreting tumor) or severe illness (sepsis).

LIPASE {#cesec75}
------

**Normal:**

22-216 IU/L (dog); 0-222 IU/L (cat).

**Interpretation:**

Increased lipase is most commonly associated with acute pancreatitis. Certain neoplasms have been reported to cause extreme elevations of lipase in the absence of pancreatic disease. There is no clinical significance associated with decreased lipase.

PHOSPHORUS (P) {#cesec76}
--------------

**Normal:**

2.0-6.7 mg/dL (dog); 2.7-7.6 mg/dL (cat).

**Interpretation:**

Increased P is normally present in young, growing dogs and cats (associated with increase SAP activity). Abnormal elevations are most likely to occur in patients with chronic renal failure or hypoparathyroidism. Improper sample handling (hemolysis) can cause elevations in P. Decreased P is expected in patients with primary hyperparathyroidism (with increased calcium), renal tubular acidosis and Fanconi syndrome. Several systemic illnesses may be associated with decreased P. WARNING: Values ≤1 mg/dL may be associated with neuromuscular abnormalities and cardiac arrhythmia.

POTASSIUM (K^+^) {#cesec77}
----------------

**Normal:**

3.9-5.2 mEq/L (dog); 3.3-5.7 mEq/L (cat).

**Interpretation:**

Increased value (hyperkalemia) may indicate mineralocorticoid deficiency (Addison\'s disease or hypoadrenocorticism) but must be interpreted with serum sodium and an ACTH stimulation test. Numerous causes of decreased potassium are recognized. GI and renal losses are the most common and most significant. Persistent hypokalemia warrants significant efforts to determine the underlying cause(s).

WARNING: Potassium levels \>7.5 mEq/L may cause cardiac arrhythmias (profound bradycardia) and death. Potassium levels \<2.5 mEq/L may cause profound weakness.

SODIUM (Na^+^) {#cesec78}
--------------

**Normal:**

147-154 mEq/L (dog); 147-165 mEq/L (cat).

**Interpretation:**

Increased value (hypernatremia) may result from excess dietary consumption or severe dehydration. Decreased value (hyponatremia) may indicate mineralocorticoid deficiency (Addison\'s disease or hypoadrenocorticism) but must be interpreted in light of other tests (e.g., serum osmolality, potassium, ACTH stimulation test). Persistent diuresis caused by drugs (furosemide) or an inherent medical disorder (nephrotic syndrome) can deplete serum sodium to significantly low levels. Depending on the laboratory methodology, pseudohyponatremia may occur in patients with profoundly lipemic serum.

TOTAL PROTEIN (TP) {#cesec79}
------------------

**Normal:**

5.5-7.2 g/dL (dog); 5.4-8.9 g/dL (cat).

**Interpretation:**

TP must be evaluated with constituent proteins albumin and globulin. Increased TP (hyperproteinemia) may indicate dehydration (elevated albumin and globulin) or extreme elevations in globulin (chronic inflammation, infection, neoplasia, especially myeloma). Decreased TP may indicate increased protein loss (especially albumin), chronic malassimilation/maldigestion, starvation, or chronic illnesses (tumor cachexia).

TRIGLYCERIDE (TG) {#cesec80}
-----------------

**Normal:**

19-133 mg/dL (dog); 24-206 mg/dL (cat).

**Interpretation:**

Increased TG is normally increased in any animal during the postprandial state (with 6 hours following a meal). TG is the cause of gross lipemia when concentrations exceed \~500 mg/dL. Increased TG (in the fasted patient) is associated with familial hypertriglyceridemia, a condition most often reported in Miniature Schnauzers (other breeds and mixed breeds may be affected) born in the U.S. (the condition has not been described in Miniature Schnauzers in Europe or the United Kingdom) and certain lines of mixed-breed cats. There is no clinical significance associated with decreased TG in either the dog or cat.

SPECIAL DIAGNOSTIC TESTS AND TEST PROTOCOLS {#cesec81}
===========================================

This section includes advanced biochemical laboratory tests not typically included in routine companion animal medicine laboratory profiles. These tests are selected on the basis of abnormal findings revealed during routine physical examination and laboratory profiling. Additional special laboratory tests and test procedures can be found in the organ system-specific sections that follow (see Chapter Outline).

Note: Throughout the Special Diagnostic Test section, the following information is provided, where appropriate, for each laboratory test described:•Test or analyte name (abbreviations or common names)•Normal (representative reference range value for normal adult dogs and cats)•Patient preparation (includes any special requirements before sample collection)•Sample (type of sample and recommended minimum volume to be collected)•Submit (component of sample to submit for analysis, store, or mail)•Interpretation (basic interpretation of test results that are outside the reference range)•Interference (variables that may falsely elevate or decrease test results)•Protocol (as applicable, accepted procedures for performing the test are outlined)

ACTH STIMULATION TEST: See ENDOCRINOLOGY {#cesec82}
----------------------------------------

 

ADRENOCORTICOTROPIC HORMONE (ACTH) Endogenous: See ENDOCRINOLOGY {#cesec83}
----------------------------------------------------------------

 

ALDOSTERONE: See ENDOCRINOLOGY {#cesec84}
------------------------------

 

AMMONIA (NH~3~) (FASTING AMMONIA) {#cesec85}
---------------------------------

 

**Normal:**

45-120 μg/dL (dog); 30-100 μg/dL (cat).

**Patient Preparation:**

Overnight fast.

**Collect:**

Whole blood, 2.0 mL minimum, in EDTA (purple-topped tube) or in heparin.

**Submit:**

Plasma, 1.0 mL minimum.

**Interpretation:**

Decreased levels of ammonia are not considered clinically significant. Elevated ammonia levels support the diagnosis of underlying, significant liver disease. This test generally is considered a liver function test and usually is performed to support a diagnosis of hepatic encephalopathy. Fasting ammonia and ammonia tolerance tests are *uncommonly performed today* because of sample instability and specimen handling requirements. These tests have largely been replaced by pre-- and post--bile acid assay.

**Interference:**

Hemolysis; elevated BUN; glucose values \>600 mg/dL. NH~3~ is unstable if not frozen at −20° C. LIMITING FACTORS: ideally, blood should be collected in a sealed, cold *glass* collection tube, centrifuged immediately, and plasma analyzed within 20 minutes of collection. Alternatively, plasma can be stored for up to 48 hours if frozen immediately after collection and kept frozen until time of analysis.

AMMONIA TOLERANCE TEST {#cesec86}
----------------------

**Normal Resting Values:**

45-120 μg/dL (dog); 30-100 μg/dL (cat).

NOTE: Minimal change should be detected following oral challenge because clearance is nearly 100% following a single pass through the liver.

**Patient Preparation:**

Overnight fast.

**Collect:**

Whole blood, 2.0 mL minimum, in EDTA (purple-topped tube) or in heparin.

**Submit:**

Plasma, 1.0 mL minimum, for each pre- and post challenge sample.

**Interpretation:**

Elevated ammonia levels support the diagnosis of underlying, significant liver disease. This generally is considered a liver function test and is usually performed to support a diagnosis of hepatic encephalopathy. Fasting ammonia and ammonia tolerance tests are *uncommonly performed today* because of sample instability and specimen handling requirements. These tests have largely been replaced by pre-- and post--bile acid assay.

**Interference:**

Hemolysis; elevated BUN; glucose values \>600 mg/dL. NH~3~ is unstable if not frozen at −20° C. LIMITING FACTORS: Ideally, blood should be collected in a sealed, cold *glass* collection tube, centrifuged immediately, and plasma analyzed within 20 minutes of collection. Alternatively, plasma can be stored for up to 48 hours if frozen immediately after collection and kept frozen until time of analysis.

**Protocol:**

Two plasma samples are required. The first is a baseline sample. The second sample is collected 30 to 45 minutes following administration of ammonium chloride (NH~4~Cl) at 100 mg/kg body weight as an oral 5% solution in approximately 20-50 mL of saline. NH~4~Cl is also available as a powder that can be administered orally, at the same dose, which lowers the risk of vomiting/aspiration.

ANTINUCLEAR ANTIBODY (ANA): SEE IMMUNOLOGY {#cesec87}
------------------------------------------

 

BILE ACIDS {#cesec88}
----------

**Normal (dog and cat):**

Pre-feeding, ≤7 μmol/L; Post-feeding, ≤15 μmol/L.

**Patient Preparation:**

12-hour or overnight fast before collecting the pre-feeding sample.

**Collect:**

Whole blood, 2.0 mL minimum, in red-topped tube for each sample collected.

**Submit:**

Serum, 1.0 mL minimum, for each sample submitted.

**Interpretation:**

Bile acids are indicated for the assessment of hepatobiliary disease in *non-icteric* patients. There is no value in performing this test in patients that are icteric. Hepatobiliary disease (e.g., portosystemic shunt) is supported with *either* a pre-feeding sample \>7 μmol/L or a post-feeding sample \>15 μmol/L. NOTE: Reference range values may vary among different laboratories.

**Interference:**

Lipemia; icterus; hemolysis. Results in patients that vomit the meal prior to collecting the 2-hour post-feeding sample cannot be expected to be reliable. Individual variations in gastric emptying and absorption can result in discordant results (e.g., the pre-feeding sample is higher than the post-feeding sample). Such results are not reliable and the test should be repeated.

**Protocol:** 1.The pre-feeding (or fasting) blood sample is collected following a 12-hour fast. Label the tube accordingly.2.Feed a relatively high-fat meal (to stimulate gallbladder contraction). A protein-restricted diet with corn oil added is appropriate for those patients with protein intolerance and signs of hepatic encephalopathy.3.Two hours following consumption of the meal, collect the post-feeding sample. Label the tube accordingly.

BLOOD GASES (ARTERIAL AND VENOUS) {#cesec89}
---------------------------------

NOTE: values represented below are expected from patients breathing room air.

**Normal**:

ArterialVenousValueDogCatDogCatpH7.36--7.447.36--7.447.34--7.467.33--7.41PCO~2~36--4428--3232--4934--38PO~2~90--10090--10024--4835--45TCO~2~25--2721--2321--3127--31HCO~3~^−^24--2620--2220--2922--24

**Patient Preparation:**

Patients breathing 100% oxygen at the time of sample collection are expected to have different results than those of patients that are breathing room air during sample collection. Note the conditions under which the sample was collected.

**Collect:**

Whole blood, either arterial or venous, depending on the assessment required.

**Submit:**

*Sample cannot be stored.* Immediate testing is required to obtain reliable results.

**Interpretation:**

T[co]{.smallcaps} ~2~ is synonymous with HCO~3~ ^−^ in patients breathing room air. The overall interpretation of venous and/or arterial blood gas results will vary considerably depending on the patient\'s health status. Several variations in test results are possible. The clinician should consult appropriate references to interpret results of individual patients (see Section 1).

**Interference:**

The test should be performed immediately on collecting the sample. Delays could cause significant abnormalities in actual results. Exposure of the sample to room air (bubbles within the sample) may cause P[co]{.smallcaps} ~2~ to decrease, whereas pH and P[o]{.smallcaps} ~2~ may increase.

BODY FLUIDS (SUBMITTED FOR CHEMISTRY ANALYSIS) {#cesec90}
----------------------------------------------

**Normal**:

Not applicable.

**Patient Preparation:**

When feasible, the skin over the site selected for centesis should be shaved and surgically prepared prior to attempting sample collection to avoid contamination of either the sample or the body cavity from which the sample is collected.

**Collect**:

1-2 mL, minimum, by direct centesis of body cavity or fluid-filled compartment.

**Submit**:

Centrifugation of whole blood contamination is indicated to remove particulate material (e.g., blood cells, cellular debris) when prompt evaluation of specimen is not possible.

**Interpretation**:

Any biochemical analyte determined in serum or plasma may be assayed in body fluid---e.g., amylase, lipase (pancreatitis), urea nitrogen, creatinine (ruptured bladder), glucose, lactate

**Interference**:

Interference from blood and blood components, bilirubin, bile, and urine may significantly interfere with test results. Centrifugation of the sample (blood contamination) may be necessary before performing any biochemistry test.

CALCIUM, IONIZED (iCa) {#cesec91}
----------------------

**Normal**:

1.12-1.42 mmol/L (dog); 1.12-1.42 mmol/L (cat)

**Patient Preparation**:

None.

**Collect:**

Whole blood, 2.0 mL.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Results reflect the concentration of the biologically active, ionized fraction of calcium without the influence of plasma proteins (e.g., albumin).

**Interference:**

The reported values of iCa can vary with patient\'s blood pH; iCa decreases as pH increases.

CEREBROSPINAL FLUID (CSF) {#cesec92}
-------------------------

**Normal:**

ValueDogCatWBCs (× 10^3^/L)≤3≤2RBCs (×10^6^/L)≤30≤30Protein (mg/dL)≤33≤36**Cytology (%)**Monocytes8769--100Lymphocytes40--27Neutrophils30--9Eosinophils00Macrophages60--3

**Patient Preparation:**

General anesthesia is required. For a description of the technique for collecting spinal fluid from dogs and cats, see section 4, Advanced Procedures. Specific training and/or experience is strongly recommended before collecting CSF from the cisterna magna (between the head and C1). Fatalities can result from improper technique.

**Collect:**

Usually, two 0.5- to 1.0-mL samples are collected in red-topped tube (no additives).

**Submit:**

Samples collected.

**Interpretation:**

If one sample contains excessive numbers of neutrophils, the second sample is submitted for culture and sensitivity; treatment recommendations should include use of an antibiotic (preferably intravenous) that will penetrate the blood-brain barrier.

**Interference:**

Blood contamination is the most common interfering factor. An RBC count greater than 30 × 10^6^/L is consistent with peripheral blood contamination. Immediate analysis is recommended. It is not recommended to submit CSF via mail for assessment.

**Protocol:**

Proper patient preparation and collection technique is critical (see Section 4).

COBALAMIN (VITAMIN B~12~) {#cesec93}
-------------------------

**Normal:**

Results vary considerably among laboratories; consult individual laboratory.

**Patient Preparation:**

Fasted.

**Collect:**

Whole blood, 2.0 mL minimum (red-topped tube).

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Test usually is performed with folate and trypsin-like immunoreactivity (TLI). It is used in the assessment of chronic small bowel diarrhea with associated weight loss. Significantly decreased cobalamine supports the need to measure TLI (exocrine insufficiency) and also supports mucosal disease, and may be indicative (in cats) of hepatic disease (hepatic lipidosis).

**Interference:**

Hemolysis; lipemia.

ETHYLENE GLYCOL[\*](#fn3){ref-type="fn"} {#cesec94}
----------------------------------------

**Normal:**

Negative. "Trace" amounts may be detected in normal patients.

**Patient Preparation:**

None.

**Collect:**

Urine (within 3-6 hours of ingestion), whole blood, or serum. Collect volume of sample in accordance with manufacturer\'s directions.

**Submit:**

Not applicable. Procedure is an in-hospital test kit for emergency use.

**Interpretation:**

Values \>20-50 mg/dL indicate exposure to ethylene glycol. Immediate treatment is indicated. Supporting laboratory documentation of ethylene glycol exposure is based on results of serum osmolality (increased), demonstration of an osmolar gap, and anion gap (increased). Blood gas analysis may reveal severe metabolic acidosis. In addition, urine examined under polarizing light microscopy may detect calcium oxalate crystals if examined within 3-6 hours post ingestion.

**Interference:**

Some drugs (pentobarbital and diazepam) will cause false elevations of ethylene glycol in the test kit results but will not induce calcium oxalate crystalluria.

**Protocol:**

Follow manufacturer\'s recommendations for use of the test kit.

FECAL FAT, 72-HOUR QUANTITATIVE COLLECTION {#cesec95}
------------------------------------------

NOTE: No one wants to either collect or analyze a pound of feces. Better tests are available. See Trypsin-Like Immunoreactivity (TLI) in this section.

FECAL OCCULT BLOOD {#cesec96}
------------------

**Normal:**

Negative for blood (dog and cat).

**Patient Preparation:**

Discontinue all red meat and orally administered drugs at least 3 days before collecting the sample for analysis (see Interference).

**Collect:**

Fresh feces.

**Submit:**

1 g of fresh feces is sufficient. NOTE: Sample may be stored for up to 4 days at 2° to 8° C.

**Interpretation:**

Guaiac test methodology is used to detect the presence of occult blood. Animals with two positive consecutive test results 48 hours apart are likely to have a primary lesion in the gastrointestinal tract. Benign ulcerative lesion and neoplasia are the two principal rule-outs.

**Interference:**

Thrombocytopenia; known platelet disorder; recent aspirin administration; corticosteroid therapy (oral or parenteral); oral iron supplementation; diet containing red meat.

FOLATE {#cesec97}
------

**Normal:**

Results vary considerably among laboratories; consult individual laboratory.

**Patient Preparation:**

Overnight fast.

**Collect:**

Whole blood, 4.0 mL (red-topped tube); separate serum from cells immediately.

**Submit:**

Serum, 2.0 mL.

**Interpretation:**

Test usually is performed in conjunction with TLI and serum cobalamin (vitamin B~12~). Decreased levels of folate support the diagnosis of small intestinal mucosal disease. Increased levels of folate support exocrine pancreatic insufficiency and/or small intestinal bacterial overgrowth.

**Interference:**

Hemolysis; lipemia.

FRUCTOSAMINE {#cesec98}
------------

**Normal:**

225-375 μmol/L (dog and cat).

NOTE: consult individual laboratory because test results may vary.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL (red-topped tube).

**Submit:**

Serum, 1.0 mL; sample must be frozen and shipped on cold packs for overnight delivery.

**Interpretation:**

This is a single-sample test representing mean blood glucose over the last 1 to 3 weeks. Increased fructosamine indicates poor glycemic control (hyperglycemia); declining fructosamine indicates improved or adequate glycemic control. Values \>500 μmol/L suggest inadequate glycemic control over the past 1 to 3 weeks. Values less than the lowest reference range value suggest that the patient has sustained significant periods of hypoglycemia over the past 1 to 3 weeks. Values \<400 μmol/L *and* clinical signs of polyuria/polydipsia (PU/PD) and polyphagia are suggestive of a Somogyi phenomenon. Fructosamine levels should *not* be used to make specific adjustments in daily insulin therapy.

**Interference:**

The assay is a colorimetric procedure; therefore, significant hemolysis or icterus could affect results. Hypoproteinemia and/or hypoalbuminemia will cause falsely low values. Hyperlipidemia and azotemia may also alter results similarly.

GLYCOSYLATED HEMOGLOBIN (GLYCATED HEMOGLOBIN; Gly Hb) {#cesec99}
-----------------------------------------------------

**Normal:**

1.7% to 4.9% (dog and cat).

NOTE: consult individual laboratory because test results may vary.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL in EDTA (purple-topped tube).

**Submit:**

Plasma, 1.0 mL; separate plasma and refrigerate until assayed.

**Interpretation:**

This is a single-sample test representing mean blood glucose over the lifespan of red blood cells (\~3-4 months). This test is used less in veterinary medicine than the fructosamine assay. In dogs, values consistently between 4% and 6% are associated with adequate glycemic control and owner satisfaction.

**Interference:**

Storage at room temperature and for longer than 7 days will decrease values; patients with a hematocrit (Hct) \<35% may have lower than expected values. NOTE: laboratories must use an assay that has been validated for dogs and for cats. Human assays performed on animal plasma may not be valid.

IRON {#cesec100}
----

**Normal:**

NOTE: Consult individual laboratory because test results may vary.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL (red-topped tube).

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Results should be interpreted with total iron-binding capacity (TIBC) and ferritin. Decreased values reflect chronic, not acute, blood loss (e.g., hookworms, intestinal ulceration, bleeding from neoplasia). In cases of iron deficiency, expect TIBC to be normal or high, whereas serum ferritin will be low. Patients with anemia associated with chronic inflammatory disease are expected to have normal to low TIBC, whereas serum ferritin will be normal to high.

**Interference:**

Hemolysis; lipemia.

LACTIC ACID (LACTATE) {#cesec101}
---------------------

**Normal:**

2-13 mg/dL (0.22-1.44 mmol/L) (dog); results not reported for cats.

**Patient Preparation:**

Avoid venous stasis when collecting sample. Clean venipuncture and rapid draw of sample is important.

**Collect:**

Whole blood, 2.0 mL, in lithium heparin plasma or in iodoacetate tubes. Some laboratories will accept samples collected in fluoride tubes.

**Submit:**

Plasma, which should be rapidly separated from blood. If this is not possible, the sample may be refrigerated immediately at 4° C, but only for 2 hours, at which time the plasma must be separated from blood.

**Interpretation:**

Resting values \>6.0 mmol/L indicate severe acidosis and a poor prognosis. Test is also used to assess metabolic myopathies, especially in Labrador Retrievers.

**Interference:**

Aspirin, phenobarbital, and epinephrine may alter lactate values. Also, allowing the sample to sit at room temperature will result in increased level of lactate.

**Protocol:**

To diagnose metabolic myopathy in Labrador Retrievers: two samples are recommended; the first blood sample is collected at rest. A second sample is collected following 10-15 minutes of brisk walking/running.

LEAD, BLOOD {#cesec102}
-----------

**Normal:**

Results vary considerably among laboratories; consult individual laboratory. Usually, values \<0.05 ppm in whole blood (or \<3 ppm in liver or kidney) are within the range of normal.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in EDTA (lavender-topped tube) or heparin.

**Submit:**

Entire sample.

**Interpretation:**

Refer to the individual laboratory for specific interpretation of the values reported. Values \>0.3 ppm suggest exposure. Values \>0.4 ppm are generally considered diagnostic of toxicosis.

**Interference:**

Incorrect tube used for collection/storage of whole blood.

LIPOPROTEIN ELECTROPHORESIS {#cesec103}
---------------------------

**Normal:**

Normal values have not been established for the dog and cat.

**Patient preparation:**

12-hour fast.

**Collect:**

Whole blood, 1.0 mL (red-topped tube).

**Submit:**

Serum, 0.5 mL.

**Interpretation:**

Test consists of electrophoretic separation of various lipoprotein categories in serum. It may qualitatively identify various categories of lipoproteins, including chylomicrons, very-low-density lipoproteins (VLDLs), low-density lipoproteins (LDLs), and high-density lipoproteins (HDLs). Standards have not been established for the dog or cat.

**Interference:**

Lipemia is not an interfering factor because electrophoresis will separate various lipid fractions.

MAGNESIUM (Mg) {#cesec104}
--------------

**Normal:**

1.5-2.5 mg/dL (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Increased Mg may reflect renal failure or insufficiency. Decreased Mg is observed in many gastrointestinal disorders (malabsorption, pancreatitis, chronic diarrhea), renal disease (glomerulonephritis, diuresis, tubular necrosis), and multiple endocrine diseases, as well as with sepsis, blood transfusion, and parenteral nutrition.

**Interference:**

Mg-containing drugs (oral antacids and laxatives) will falsely elevate test results. Some intravenous fluids contain Mg, which also may falsely elevate test results. Falsely decreased values may result from diuretic therapy or intravenous fluid therapy--induced diuresis.

OSMOLALITY, ESTIMATED (SERUM) {#cesec105}
-----------------------------

**Normal:**

290-310 mOsm/kg (dog); 308-335 mOsm//kg (cat).

**Patient Preparation:**

None.

**Collect:**

Whole venous blood, 2.0 mL, in a red-topped tube or serum separator tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Osmolality of extracellular fluid (ECF) is determined predominantly by electrolytes, especially sodium, and small molecules (glucose and urea) and is reflective of fluid shifts between the vascular space and the interstitium. Increased ECF osmolality (\>350 mOsm/L), or hyperosmolality, is likely to be associated with clinical signs (especially neurologic) because of the shift of water from the interstitial space into the vascular space.

NOTE: Direct laboratory measurement of serum osmolality can be performed but is expensive. Serum osmolality is usually calculated according to the following formula:$$\text{mOsm}/\text{kg} = 1.86(\text{Na}^{+} + \text{K}^{+}) + (\text{glucose} \div 18) + (\text{BUN} \div 2.8) + 9$$

PANCREATIC LIPASE IMMUNOREACTIVITY (PLI) {#cesec106}
----------------------------------------

**Normal:**

2.2-102.1 μg/L (dog); 2.0-6.8 μg/L (cat)

**Patient Preparation:**

Fasted for 12 hours before collecting blood.

**Collect:**

Whole blood, 3.0 mL minimum in red-topped tube or serum separator tube.

**Submit:**

Serum,1.0 mL minimum. *Immediately s* eparate serum from clot. Ship serum only. Do not ship whole blood.

**Interpretation:**

NOTE: PLI is species-specific; samples must be labeled "DOG" (cPLI) or "CAT" (fPLI). **Interference:**

Anticoagulant, hemolysis; moderate or greater lipemia.

**Protocol:**

Serum should be separated *immediately* following clot formation and retraction.

PROTEIN ELECTOPHORESIS (SERUM) {#cesec107}
------------------------------

**Normal:**

ValueDogCatTotal protein (g/dL)6.0--7.67.3--7.8Albumin (g/dL)2.7--3.72.8--4.2α1-Globulin (g/dL)0.25--0.600.3--0.65α2-Globulin (g/dL)0.72--1.400.40--0.68β1-Globulin (g/dL)0.63--0.890.77--1.25β2-Globulin (g/dL)0.60--1.00.35--0.50γ1-Globulin (g/dL)0.50--0.831.39--2.22A:G ratio0.8--1.00.63--1.15

**Patient Preparation:**

Fasted for 12 hours (overnight) to prevent postprandial lipemia.

**Collect:**

Whole blood, 2.0 mL (red-topped tube).

**Submit:**

Serum, 1.0 mL (most laboratories will accept a volume of serum from 0.5 to 1.0 mL).

**Interpretation:**

Multiple interpretations are possible, depending on the patient\'s condition. Test usually is performed to assess degree of loss of albumin or increases in one or more globulin fractions (e.g., hypergammaglobulinemia associated with FIP, canine ehrlichiosis, multiple myeloma). The test is NOT used to confirm a diagnosis.

NOTE: Most clinical assessments are made from the shape of the curve in a densitometer tracing of the electrophoresis rather than specific numbers. When requesting serum protein electrophoresis, it is important to request a copy of the curve as well as the quantitated results for each protein fraction.

**Interference:**

Lipemia; hemolysis.

TRYPSIN-LIKE IMMUNOREACTIVITY, CANINE (CANINE TLI) {#cesec108}
--------------------------------------------------

**Normal:**

5.0-35.0 μg/L.

**Patient Preparation:**

Fasted.

**Collect:**

Whole blood, 2.0 mL in red-topped tube.

**Submit:**

Serum, 1.0 mL. Separate serum from clot. Ship serum only. Do not ship whole blood.

**Interpretation:**

NOTE: TLI is species-specific; samples must be labeled "DOG". It is a sensitive and specific test for the diagnosis of exocrine pancreatic insufficiency in dogs and cats. Values \<2.5 μg/L, in the presence of clinical signs, support the diagnosis. Values \>50 μg/L have been used to diagnose pancreatitis in dogs. However, TLI has been replaced by the canine pancreatic lipase immunoreactivity (cPLI) assay to diagnose pancreatitis in dogs.

**Interference:**

Hemolysis; moderate or greater lipemia.

TRYPSIN-LIKE IMMUNOREACTIVITY, FELINE (FELINE TLI) {#cesec109}
--------------------------------------------------

**Normal:**

12-82 μg/L.

**Patient Preparation:**

Fasted.

**Collect:**

Whole blood, 2.0 mL (red-topped tube).

**Submit:**

Serum, 1.0 mL. Separate serum from clot. Ship serum only. Do not ship whole blood.

**Interpretation:**

NOTE: TLI is species-specific; samples must be labeled "CAT". This is a sensitive and specific test for the diagnosis of exocrine pancreatic insufficiency in dogs and cats. Values \<2.5 μg/L in the presence of clinical signs supports the diagnosis. Values \>100 μg/L have been used to diagnose pancreatitis in cats. However, TLI has been replaced by the feline pancreatic lipase immunoreactivity (fPLI) assay to diagnose pancreatitis in cats.

**Interference:**

Hemolysis; moderate or greater lipemia.

**Note:** Serum for PLI and TLI assays may be submitted to the Gastrointestinal Laboratory Department of Small Animal Medicine and Surgery, Texas A &M University, 4474 TAMU, College Station, Texas, 77843-4474.

HEMOSTASIS AND COAGULATION {#cesec110}
==========================

Tests of hemostasis are directed at determining platelet numbers and function, activation and abnormalities of the intrinsic and extrinsic clotting cascade, and quantitation of breakdown products of thrombosis and fibrinolysis. Obtain blood samples for evaluation of coagulation abnormalities by careful venipuncture, and insert samples into plastic or silicone-coated glass syringes.

Because tissue thromboplastin can activate the clotting cascade, some authors advocate using two syringes and two needles to obtain blood for coagulation tests. First, carefully insert the needle into the vein and withdraw 1 mL of blood. Leave the needle in the vessel, and remove the first syringe. Attach a second syringe and obtain the appropriate volume of blood; then remove the needle from the vessel. Rapidly replace the needle on the second syringe with a fresh needle and then inject the blood sample into the appropriate tubes for later analyses.

Platelet tests should be performed on fresh samples within 2 hours of collection. Plasma samples can be spun down and frozen at −20° C for several days, and at −40° C for several months to a year for later analyses.

INITIAL IN-OFFICE SCREENING TESTS {#cesec111}
---------------------------------

The initial in-office screening tests for coagulation defects include a hematocrit (Hct), peripheral blood smear, activated coagulation test (ACT) or activated partial thromboplastin time (APTT), prothrombin time (PT), and, if indicated, buccal mucosal bleeding time assay.

### Hematocrit {#cesec112}

The patient\'s hematocrit and total protein should be evaluated to determine whether anemia is present. The color of the plasma in the spun-down microhematocrit tube can aid in making a diagnosis if intravascular hemolysis (red) or icterus (yellow) is present. The buffy coat from a microhematocrit tube can be evaluated microscopically for the presence of microfilaria in heartworm disease or mast cells in systemic mastocytosis.

### Peripheral Blood Smear {#cesec113}

The peripheral blood smear should be evaluated for RBC morphology, RBC fragments (schizocytes), platelet count, large platelets, WBC count and morphology, and blood parasites.

### Platelet Count {#cesec114}

One of the most simple cage-side tests when determining the cause of a coagulopathy is the platelet count. To perform this test:1.Obtain an anticoagulated (trisodium citrate or sodium oxalate are the anticoagulants of choice for platelet and coagulation testing) sample of peripheral blood, and make a stained blood smear.2.Scan the slide, including the peripheral edge, for platelets and platelet clumps. If platelet clumps are present, the platelet estimate cannot be accurately measured; also, it is unlikely that thrombocytopenia is the cause of the patient\'s hemorrhage.3.If no platelet clumps are present in the feathered edge of the blood smear, scan multiple areas of the slide on 100× (oil) magnification. Count the number of platelets per high-power field (hpf) and then multiply the value by 15,000 to give an approximate estimation of platelet number.

Hemorrhage secondary to thrombocytopenia occurs when platelet numbers decrease to \<40,000/uL (\<2-3 platelets/hpf). If there are signs of superficial hemorrhage and more than 4-5 platelets/hpf, a thrombocytopathia (platelet function problem) such as von Willebrand\'s disease, DIC, or aspirin-induced coagulopathy may be present.

### Activated Coagulation (Clotting) Time (ACT) {#cesec115}

The ACT measures the function of the intrinsic and common coagulation pathway (factors II, V, VIII, IX, X, XI, and XII). The ACT can be used reliably to screen for disorders of secondary hemostasis. Severe thrombocytopenia (\<10,000-20,000 platelets/μL) and decreased fibrinogen, in addition to decreases in activated clotting factors listed previously, can cause prolongation in the ACT. An ACT tube contains diatomaceous earth that stimulates blood clotting on contact.

To perform the ACT:1.Warm the ACT tube to 37° C in a heating block or water bath.2.Use a 3-mL syringe without any anticoagulant to obtain 3.0 mL of blood. The venipuncture should be atraumatic. Because tissue factor stimulates the clotting cascade, quickly change the needle and push 2.0 mL of the blood sample into the ACT tube, inverting the tube several times to mix the contents, and then place the tube in the water bath or heat source. Start counting the time at the moment you inject the blood into the tube. (The remaining blood can be used to fill microhematocrit tubes and make peripheral blood smears.)3.To check the tube for clots, quickly invert the tube and then return it to the heat source at 60 seconds and then every 5 seconds thereafter. Record the time that the first signs of a clot (gel) is observed.

Normal ACT time is 90-120 seconds for dogs, and 80-100 seconds for cats.

Activated partial thromboplastin time (APTT) is another, more sensitive test to detect defects in the intrinsic clotting cascade. It is more sensitive than the ACT in that it will become prolonged earlier than the ACT. Point-of-care coagulation analyzers (SCA-2000, Symbiotics, Inc., San Diego) are available that require less blood than an ACT, and thus may be the preferred test.

### Prothrombin Time (PT) {#cesec116}

PT is a test to determine abnormalities in the extrinsic (factor VII) coagulation pathway. Because factor VII is the most labile clotting factor and has the shortest half-life, PT will become prolonged before any changes in ACT or APTT (intrinsic pathway). The prothrombin-complex clotting factors are II, VII, and X; these factors interact with factor V and fibrinogen in the presence of tissue thromboplastin and calcium chloride.

### Buccal Mucosal Bleeding Time (BMBT) {#cesec117}

The BMBT measures the time required for platelets to become activated and interact with damaged vascular endothelium to form a primary platelet plug. It is a test of primary hemostasis. The BMBT becomes prolonged with thrombocytopenia (\<100,000/μL) and platelet dysfunction syndromes such as von Willebrand\'s disease. The BMBT is usually performed without any sedation in dogs and with ketamine in cats.

To perform the BMBT:1.When performing the BMBT in dogs, place a loose tie of gauze around the dog\'s muzzle to lift the lip so that the buccal mucosa is exposed and the veins slightly engorged. It is important to not tie the gauze too tightly, as vasoconstriction can artifactually change test results.2.Use a BMBT template (Simplate R) to make two small nick incisions in the buccal mucosa. Gently wick the blood away from the site with a piece of filter paper (if you don\'t have filter paper, a coffee filter works well). Allow the blood to wick into the filter paper without touching the incisions or the clot.3.Note the time from making the initial incision to the time that hemorrhage stops (i.e., a platelet plug has formed). Normal BMBT is less than 3 minutes in dogs and cats.

If the BMBT is prolonged, von Willebrand\'s disease, NSAID influence, congenital thrombopathies (Bassett and Otter Hounds), and systemic illness (azotemia, hepatic failure, malignancy) should be ruled out. If the BMBT is normal in the face of a normal platelet count and clinical bleeding, tests of the coagulation cascade (APTT, PT, ACT) should be considered.

ANCILLARY TESTS OF HEMOSTASIS {#cesec118}
-----------------------------

### Thrombin Time {#cesec119}

The thrombin time is a measure of the amount of functional fibrinogen in plasma. The test is used in the diagnosis of DIC when fibrinogen levels are low. Fibrinogen levels may also be normal in DIC, but thrombin time will still be altered because of in vivo fibrinolysis. This test is now rarely used, because since more sensitive and specific tests such as D-dimer concentration are available for the diagnosis of DIC.

### Fibrinogen {#cesec120}

Fibrinogen levels are used in the detection of DIC. In DIC, fibrinogen levels can *decrease* as a result of the activation of thrombin and fibrin formation and the activation of plasmin, which causes degradation of fibrin and fibrinogen. Fibrinogen levels can be decreased, normal, or increased in cases of chronic DIC due to a compensatory overproduction. Because of the variability in fibrinogen levels, this test alone is not conclusive to make a diagnosis of DIC.

### Fibrin(ogen) Degradation Products (FDPs) {#cesec121}

FDPs (also called fibrin split products \[FSPs\]) are formed when the enzyme plasmin acts on fibrin monomers, cross-linked fibrin, and fibrinogen. Because fibrinogen can *increase* during periods of inflammation without DIC, the presence of FDPs alone does not allow a diagnosis of DIC. FDPs are cleared by the hepatic reticuloendothelial system. In cases of hepatic insufficiency or hepatic failure, FDPs can be elevated without concurrent DIC.

### D-Dimers {#cesec122}

D-dimers are used in the diagnosis of DIC. D-dimers are released as the result of the breakdown of cross-linked fibrin by plasmin. Because D-dimers occur as a result of a stable fibrin clot, elevated levels are more sensitive and specific for a diagnosis of DIC.

### The PIVKA Test {#cesec123}

The PIVKA (proteins induced by vitamin K absence or antagonism) test is most useful in diagnosing vitamin K deficiencies. Moderate deficiencies in Vitamin K--dependent coagulation factors (II, VII, IX, and X) will cause abnormal PIVKA test results. The PIVKA test becomes prolonged 12-24 hours after the PT test becomes prolonged.

### Saline Agglutination {#cesec124}

The saline agglutination test is simple to perform in-house and aids in the diagnosis of immune-mediated hemolytic anemia. To perform a saline agglutination test:1.Place one drop of 0.9% saline on a microscope slide. Mix the drop of saline with one drop of the patient\'s anticoagulated blood and observe for the presence of agglutination under the microscope.2.If agglutination is present, mix a second drop of saline with the blood-saline mixture on the slide and review under the microscope a second time.

If the "agglutination" disperses, it is likely caused by rouleaux secondary to inflammation. If the agglutination remains, autoagglutination of red blood cells is occurring due to interaction with antibodies directed against glycoprotein moieties on the surface of the RBC membranes.

**Note:** Management of patients with a confirmed coagulopathy involves correcting any underlying cause, replenishing oxygen-carrying capacity in the form of red blood cells or purified hemoglobin, replacing clotting factors and antithrombin in the form of fresh frozen plasma, and maintaining end-organ perfusion. The management of specific conditions and coagulopathies is listed under their subheadings. A more thorough approach to transfusion management is listed in Section 1.

SUBMISSION OF SAMPLES FOR COAGULATION TESTING {#cesec125}
---------------------------------------------

1.Draw blood sample into a blue-top tube (BTT) that contains sodium citrate. Fill the BTT to at least 75%, but preferably 90% or more, because results will be affected by excess citrate anticoagulant.2.Centrifugation and separation of plasma from cells is *strongly recommended* if transportation to the laboratory may require more than 12 hours.3.Use a plastic pipette or small syringe to transfer the plasma to a clean plastic tube. Cap the tube and keep cold or freeze at −20° C or lower. Freezing the plasma is not necessary unless testing will be delayed for more than 24 hours, but it should always stay cold. Repeated freezing and thawing of plasma denatures coagulation proteins.4.If samples will be mailed, ship overnight with frozen cold packs.

ACTIVATED COAGULATION (CLOTTING) TIME (ACT) {#cesec126}
-------------------------------------------

**Normal:**

90-120 seconds (dog); 80-100 seconds (cat).

**Patient Preparation:**

Direct penetration of the vein is important.

**Collect:**

Venous blood in an ACT Vacutainer tube. Fill to maximum allowed by vacuum.

**Submit:**

Blood sample in collection tube per protocol.

**Interpretation:**

ACT is a convenient in-hospital screening test that evaluates both the intrinsic and common coagulation pathways. Prolonged clotting time implies coagulation factor deficiency. A specific coagulation factor deficiency must be less than 5% to increase the ACT. NOTE: hemophiliac patients may have factor VIII or IX activity only 40% to 60% of normal and yet would have a normal ACT (and a normal APTT).

**Interference:**

The presence of tissue thromboplastin in sample (e.g., failing to obtain blood from a "clean" venipuncture) will activate the extrinsic pathway.

**Protocol:**

A two-tube technique is recommended to eliminate any chance of tissue thromboplastin contaminating the sample. Fill two tubes from the same draw. Use the second tube only. Pre-warm the tubes in a water bath or heating block (37° C). Place the filled sample tubes in the water bath or heating block and begin timing. Incubate the sample in the collection tube for 60 seconds for dogs, and 45 seconds for cats. Invert sample every 5 seconds to assess for evidence of clot formation. Stop procedure at first sign of clot formation.

ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) {#cesec127}
--------------------------------------------

**Normal:**

8.6-12.9 seconds (dog); 13.7-30.2 seconds (cat).

**Patient Preparation:**

None (atraumatic venipuncture is recommended).

**Collect:**

Venous blood in citrate (blue-topped tube); fill Vacutainer tube to the maximum allowed by the vacuum.

**Submit:**

Citrated plasma only (plasma must be separated from cells) in red-topped tube.

**Interpretation:**

APTT is the most sensitive and specific test of coagulation factor activity. Prolonged APTT implies anticoagulant therapy (heparin) or specific coagulation factor deficiency.

**Interference:**

Clotted sample, failure to use citrate as the anticoagulant; incorrect ratio of citrate to whole blood.

**Protocol:**

On collection of blood, invert tube several times to assure adequate mixing of sample and anticoagulant. Centrifuge IMMEDIATELY. Transfer plasma to red-topped tube and label as Citrated Plasma.

ANTIPLATELET ANTIBODY: SEE IMMUNOLOGY {#cesec128}
-------------------------------------

 

BLOOD TYPING, FELINE {#cesec129}
--------------------

**Normal:**

Results reported as positive or negative for blood type A, B, or AB.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 1.0 mL, in EDTA (lavender-topped tube).

**Submit:**

Entire sample.

**Interpretation:**

The majority of blood donors should be type A. However, blood typing and cross-matching blood prior to transfusion in cats is highly recommended, because some type B cats are present in the U.S. NOTE: it is reported that as little as 1.0 mL of type A blood transfused into a type B cat was fatal.

BLOOD TYPING FOR COMPLETE DOG ERYTHROCYTE ANTIGEN (DEA) {#cesec130}
-------------------------------------------------------

**Normal:**

Results are reported as positive or negative for DEA-1.1, DEA-1.2, DEA-3, DEA-4, DEA-5, and DEA-7.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 1.0 mL, in EDTA (lavender-topped tube).

**Submit:**

Entire sample.

**Interpretation:**

Universal or A-blood donors should be NEGATIVE for DEA-1.1, DEA-1.2, and DEA-1.7.

BUCCAL MUCOSAL BLEEDING TIME (BMBT) {#cesec131}
-----------------------------------

**Normal:**

2.6 ± 0.48 minutes (dog); results not reported in cats.

**Patient Preparation:**

None.

**Collect:**

Not applicable.

**Submit:**

Not applicable. This is an in-hospital screening test for platelet function.

**Interpretation:**

BMBT is a sensitive and specific test of platelet function. Prolonged BMBT is expected in patients with von Willebrand\'s disease and uremia. Test is NOT generally recommended for thrombocytopenic patients.

**Interference:**

Improper technique thrombocytopenia.

**Protocol:**

The test entails a standardized cut into the buccal mucosa with subsequent "capture" of blood onto filter paper until bleeding ceases.

CLOT RETRACTION TEST {#cesec132}
--------------------

*Not generally recommended.*

NOTE: Because of the insensitivity of this test, the clot retraction test is NOT recommended for the assessment of patients with suspected disorders of hemostasis.

COAGULATION FACTOR ACTIVITY (FACTOR ASSAY) {#cesec133}
------------------------------------------

The following inherited coagulation factor deficiencies have been reported in dogs and cats:Hemophilia A (factor VIII deficiency)---the most common factor deficiencyHemophilia B (factor IX deficiency)Factor XII deficiency (Hageman trait)---of minor significance in affected catsVitamin K--dependent factor deficiency--- occurs in Devon Rex cats, with severe bleeding

Other, rare deficiencies have been reported.

### Diagnosis of Coagulation Factor Deficiency {#cesec134}

Coagulation factor deficiency usually is suggested in the individual dog or cat on the basis of initial test results from routine coagulation profiles (see ACT, APTT, and PT in this section). occasionally, It is possible to measure activity of specific factors in individual patients. Specialized laboratories experienced in performing these assays should be consulted regarding sample, sample size, submission requirements, and interpretation.

CROSS-MATCH: MAJOR AND MINOR {#cesec135}
----------------------------

**Normal:**

Results (in dogs and cats) are reported as "compatible" ("no agglutination") or "incompatible" ("agglutination and/or hemolysis") in either major or minor cross-match tubes.

**Patient Preparation:**

None.

**Donor Preparation:**

None.

**Collect (Patient):**

Venous blood, 2 mL, in red-topped tube PLUS anticoagulated venous blood, 2.0 mL, in lavender-topped tube.

**Collect (Donor):**

The same (this is where it\'s important to label the tubes!).

**Submit (Patient):**

Serum, 1 mL, PLUS anticoagulated whole blood, 1.0 mL.

**Submit (Donor):**

The same.

**Interpretation:** *No* agglutination and/or hemolysis in either tube indicates that the match is compatible and the donor\'s blood may be used.The presence of agglutination and/or hemolysis in the *major* cross-match tube indicates that the donor\'s blood should not be used.The presence of agglutination and/or hemolysis in the *minor* cross-match tube suggests that the compatibility is not ideal; if another donor cannot be found, the blood can be used---although with caution.The presence of agglutination and/or hemolysis in the *donor control* (donor cells mixed with donor serum) suggests incompatibility; the donor\'s blood should not be used.The presence of agglutination and/or hemolysis in the *patient control* (patient cells mixed with patient serum) likely reflects the patient\'s diagnosis. Transfusion is indicated.

**Interference:**

In vitro hemolysis associated with difficulty collecting a sample or inappropriate handling of the blood; profound lipemia (lactescence).

**Protocol:** 1.Wash RBCs from patient and donor in 0.9% SALINE solution three times; add 4.8 mL of saline to 0.2 mL of RBCs from patient and donor. Mix accordingly:a.Major cross-match: Mix 0.1 mL (2 drops) of donor RBCs + 0.1 mL (2 drops) of patient serumb.Minor cross-match: Mix 0.1 mL (2 drops) of patient RBCs + 0.1 mL (2 drops) of donor serumc.Patient control: Mix 0.1 mL (2 drops) of patient RBCs + 0.1 mL (2 drops) of patient serumd.Donor control: Mix 0.1 mL (2 drops) of donor RBCs + 0.1 mL (2 drops) of donor serum2.Incubate for 15 minutes at 37° C. Centrifuge for 1 minute.3.Observe the supernatant in all tubes for evidence of hemolysis in the test samples. Examine the suspension of RBCs for agglutination (macroscopically and microscopically).

D-DIMER (FRAGMENT D-DIMER; FIBRIN DEGRADATION FRAGMENT) {#cesec136}
-------------------------------------------------------

**Normal:**

Consult laboratory reference range (dog); studies in cats are lacking.

**Patient Preparation:**

None.

**Collect:**

Anticoagulated venous blood, 2 mL, in EDTA or heparin.

**Submit:**

Plasma, 1.0 mL.

**Interpretation:**

D-dimer is the proteolytic fragment of fibrinogen degradation. D-dimer concentration is used in the assessment of DIC in dogs. Elevated levels represent a marker of clot lysis and therefore support a diagnosis of DIC; a negative test result has a high negative predictive value and reliably rules out a diagnosis of DIC. The test also has the potential to identify patients with pulmonary thromboembolic disease, although results are not reliably predictive.

**Interference:**

None reported.

FIBRINOGEN, QUALITATIVE (ESTIMATED) {#cesec137}
-----------------------------------

**Normal:**

Refer to laboratory reference range (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Whole venous blood, 2.0 mL, in EDTA (lavender-topped tube).

**Submit:**

Plasma, 1.0 mL.

**Interpretation:**

Fibrinogen levels can be estimated as the difference between plasma protein concentrations before and after heating. An increased value correlates with clot lysis and supports the diagnosis of DIC.

**Interference:**

Clots in sample.

**Protocol:**

Invert tube several times to assure adequate mixing of venous blood and anticoagulant.

FIBRINOGEN, QUANTITATIVE {#cesec138}
------------------------

**Normal:**

100-245 mg/dL (dog); 110-370 mg/dL (cat).

**Patient Preparation:**

None.

**Collect:**

Completely fill a citrated (blue-topped) tube with whole blood. *Mix thoroughly*. *Centrifuge immediately*. Transfer plasma to a red-topped tube.

**Submit:**

Plasma, 1.0 mL, in a red-topped tube; label as CITRATED PLASMA.

**Interpretation:**

Increased concentration is associated with DIC. However, there is no single test for the diagnosis of DIC. The clinician must also assess fibrin degradation products (increased), APTT (prolonged), PT (prolonged), and platelet count (decreased).

**Interference:**

Incorrect ratio of citrate (anticoagulant) to whole blood; clots in sample; use of anticoagulants other than citrate.

**Protocol:**

On collection of blood, invert tube several times to assure adequate mixing of sample and anticoagulant. *Centrifuge immediately*. Transfer plasma to a red-topped tube; (label as CITRATED PLASMA). NOTE: Sample is stable for only 24 hours if held at 2° to 8° C; for extended storage, sample must be frozen.

FIBRIN DEGRADATION PRODUCTS (FDPs; FIBRIN SPLIT PRODUCTS \[FSPs\]) {#cesec139}
------------------------------------------------------------------

**Normal:**

\<10 μg/mL (dog); \<10 μg/mL (cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in EDTA or in a red-topped tube.

**Submit:**

1.0 mL serum or plasma, 1.0 mL.

**Interpretation:**

Assay is used to document breakdown of fibrin clots. Increased concentration is associated with DIC (see also D-Dimer). However, there is no single test for DIC diagnosis. The clinician must also assess fibrinogen (increased), APTT (prolonged), PT (prolonged), and platelet count (decreased).

**Interference:**

Clots in sample.

PARTIAL THROMBOPLASTIN TIME (PTT): SEE ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) {#cesec140}
-----------------------------------------------------------------------------------

 

PIVKA TEST (PROTEINS INDUCED BY VITAMIN K ANTAGONISM TEST; "THROMBOTEST") {#cesec141}
-------------------------------------------------------------------------

**Normal:**

Refer to laboratory reference range (dog and cat).

**Patient Preparation:**

Atraumatic venipuncture is recommended.

**Collect:**

Completely fill a citrated (blue-topped) tube with whole blood. *Mix thoroughly*. *Centrifuge immediately*. Transfer plasma to a red-topped tube.

**Submit:**

Plasma, 1.0 mL, in red-topped tube; label as CITRATED PLASMA.

**Interpretation:**

Test is used in conjunction with prothrombin time in the assessment of patients suspected of warfarin toxicosis.

**Interference:**

Incorrect ratio of citrate (anticoagulant) to whole blood; clots in sample; use of anticoagulants other than citrate.

**Protocol:**

On collection of blood, invert tube several times to assure adequate mixing of sample and anticoagulant. *Centrifuge immediately*. Transfer plasma to a red-topped tube; label as CITRATED PLASMA. NOTE: Sample is stable for only 24 hours if held at 2° to 8° C; for extended storage, sample must be frozen.

PLATELET COUNT {#cesec142}
--------------

**Normal:**

166-600 × 10^3^/μL (dog); 230-680 × 10^3^/μL (cat).

**Patient Preparation:**

Atraumatic collection is recommended.

**Collect:**

Venous blood, 1.0 mL, in EDTA (lavender-topped tube).

**Submit:**

Entire sample.

**Interpretation:**

Decreased platelet count is indicative of many disorders, including immune-mediated thrombocytopenia (extremely low platelet count), infection, sepsis, and DIC, and therefore must be assessed in light of other physical, hematologic, and biochemical parameters. Elevated platelet counts (up to 1 million cells/μL) can be normal for some patients. Cats with extreme thrombocytosis should be tested for feline leukemia virus.

**Interference:**

Slow draw of blood from the vein, transfer of blood from syringe to tube, and traumatic venipuncture may falsely decrease platelet count.

PROTHROMBIN TIME (PT) {#cesec143}
---------------------

**Normal:**

5.1-7.9 seconds (dog); 8.4-10.8 seconds (cat).

**Patient Preparation:**

None.

**Collect:**

Collect whole blood in a citrated (blue--topped) tube). Fill the tube to the capacity allowed by the vacuum. Invert immediately to mix. Centrifuge immediately and collect plasma. Transfer to a sterile *plastic* tube, using *plastic* pipette. Freeze. NOTE: label as CITRATED PLASMA.

**Submit:**

Citrated plasma, 1.0 mL. Ship sample with dry ice. Store frozen.

**Interpretation:**

PT is used to assess extrinsic and common coagulation pathways. Prolonged PT is used to assess patients with suspected vitamin K antagonism (warfarin toxicosis).

**Interference:**

Incorrect ratio of citrate to whole blood; clots in specimen; use of a non-citrated anticoagulant (e.g., EDTA in lavender-topped tube). NOTE: If the citrated plasma sample contacts glass, clotting factor activation may occur.

**Protocol:**

On collection of blood, invert tube several times to assure adequate mixing of sample and anticoagulant. *Centrifuge immediately*. Transfer plasma to a red-topped tube. (Label as CITRATED PLASMA). NOTE: sample is stable for only 24 hours if held at 2° to 8° C; for extended storage, sample must be frozen.

VON WILLEBRAND FACTOR (vWD FACTOR) {#cesec144}
----------------------------------

**Normal:**

Results reported are specific for the laboratory performing the test.

**Patient Preparation:**

None.

**Collect:**

Collect whole blood in a citrated (blue-topped) tube. Fill the tube to the capacity allowed by the vacuum. Invert immediately to mix. *Centrifuge immediately* and collect plasma. Transfer to a sterile *plastic* tube, using a *plastic* pipette. Freeze. Label tube as CITRATED PLASMA. Although EDTA (lavender-topped tube) may be accepted by some laboratories, sodium citrated samples are preferred when submitting samples for vWD factor.

**Submit:**

Citrated plasma, 1.0 mL. Ship sample with dry ice. If storing longer than 24 hours, store frozen.

**Interpretation:**

vWD is the most common inherited hemostatic disorder reported in dogs. This test is usually performed to confirm the diagnosis of vWD, in conjunction with the BMBT. Although the condition is inherited, variable degrees of expression are recognized. Dogs with vWD levels ≤30% have a tendency to bleed spontaneously (e.g., epistaxis).

**Interference:**

Recent transfusion may falsely elevate vWD levels. Incorrect ratio of citrate to whole blood, a clotted specimen, and use of a non-citrated anticoagulant (e.g., EDTA in lavender-topped tube) can also affect results. Do NOT use a glass pipette or glass tube. If the citrated plasma sample contacts glass, clotting factor activation may occur.

ENDOCRINOLOGY {#cesec145}
=============

ADRENOCORTICOTROPIC HORMONE (ACTH), ENDOGENOUS {#cesec146}
----------------------------------------------

**Normal:**

10 to 70 pg/mL (dog); results not reported for cat.

**Patient Preparation:**

Patient should be hospitalized overnight.

**Collect:**

Whole blood, 2.0 mL, in EDTA (chilled, lavender-topped tube); *Immediately* transfer plasma to plastic tube (ACTH adheres to glass) and freeze. Samples should be stored frozen until assayed. Maximum storage time: 1 month at −20° C.

NOTE: Contact laboratory directly before collecting samples for ACTH. Some laboratories request plasma samples be submitted in aprotonin and will provide specially prepared tubes for this purpose. Aprotonin (protease inhibitor) is added to a lavender-topped tube to stabilize ACTH. Freezing the sample is not necessary. The treated plasma should be separated immediately by centrifugation, transferred to a plastic tube, capped, and refrigerated. Transport sample to the lab with cold packs.

**Submit:**

Plasma, 1.0 mL; sample should NOT be allowed to sit at room temperature even for a short period.

**Interpretation:**

Adrenal tumors and iatrogenic Cushing\'s syndrome are expected to suppress ACTH secretion; pituitary-dependent Cushing\'s syndrome is characterized by excessive plasma concentration of ACTH.

**Interference:**

Recent or current corticosteroid administration; "stress" at or around the time of blood collection. NOTE: samples *must* be handled quickly because ACTH disappears quickly from whole fresh blood.

**Protocol:**

Following overnight hospitalization, the sample is collected between 8 and 9 am the following morning.

ACTH STIMULATION TEST (ACTH "Stim") {#cesec147}
-----------------------------------

**Normal:**

DogCatPre-test:0.5 to 6.0 μg/dL0.5 to 5.0 μg/dLPost-test:6 to 17 μg/dL≤13 μg/dL

NOTE: 17-22 μg/dL is considered "borderline" for dogs; 13-16 μg/dL is considered "borderline" for cats.

**Patient Preparation:**

No prior treatment with corticosteroids for at least 5-7 days before testing.

**Collect:**

Heparinized whole blood, 2.0 mL (green-topped tube). NOTE: Do NOT submit blood collected in EDTA.

**Submit:**

Plasma, 0.5 mL minimum for each sample submitted; sample should be refrigerated if shipped. Sample is assayed for cortisol.

**Interpretation:**

This is the most commonly used screening test for hyperadrenocorticism in dogs and cats. Patients with pituitary-dependent hyperadrenocorticism or adrenal tumor are expected to have an exaggerated cortisol response following stimulation with ACTH, assuming that the adrenal glands have retained ACTH responsiveness. Post-stimulation values ≥22 μg/dL are considered diagnostic for hyperadrenocorticism in dogs (\>16 μg/dL in cats) in the presence of clinical signs (especially polydipsia) and supporting laboratory data and abdominal ultrasound. NOTE: ACTH stimulation does NOT differentiate between pituitary-dependent hyperadrenocorticism and adrenal tumor. An alternative test to use when screening for canine Cushing\'s syndrome is the low-dose dexamethasone test (see following entry).

The ACTH stimulation test is the *only* reliable test for monitoring patients undergoing o, p′-DDD (Lysodren) treatment of pituitary-dependent hyperadrenocorticism. Dogs with adequate pharmacologic suppression of adrenal function should have unchanged pre- and post-stimulation values (typically \<2.0 μg/dL for both).

**Interference:**

Concurrent or recent treatment with corticosteroids. Anticonvulsant medications may adversely affect test results.

**Protocol:**

Several protocols are available; the following are representative.Collect pre-test sample; then administer ACTH gel at 2.2 IU/kg IM (dog). Collect post-test sample 2 hours after ACTH administration;

orCollect pre-test sample; then administer synthetic (expensive) ACTH (tetracosactrin, cosyntropin \[Cortrosyn\]) at 0.25 mg (dog) or 0.125 mg (cat) IM or IV. Collect post-test sample 1 hour after ACTH administration (dogs).

orCollect pre-test sample; then administer ACTH at 125 μg IM (cat). Collect two post-test samples 30 minutes and 60 minutes after ACTH administration (cats).

ALDOSTERONE, SERUM {#cesec148}
------------------

**Normal:**

Pre-test, 49 pg/mL (mean); post-test, 306 pg/mL (mean); reported range, 146 to 519 pg/mL (dogs). Results not reported for cats.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in EDTA (lavender-topped tube) as baseline (pre-test); and repeat in 1 hour.

**Submit:**

Plasma, 1.0 mL, for each of the two samples collected.

**Interpretation:**

Low baseline and minimal or no increase in aldosterone levels support a diagnosis of hypoaldosteronism. The test is designed to distinguish dogs with primary hypoadrenocorticism from those with secondary hypoadrenocorticism. However, the sensitivity of the test in dogs is such that the positive predictive value is relatively low.

**Interference:**

Clots in sample.

**Protocol:**

In dogs, the pre-test and post-test samples are collected at 1-hour intervals following administration of ACTH. Follow the same protocol used to test for hyperadrenocorticism (see ACTH Stimulation).

COBALAMIN (VITAMIN B~12~) {#cesec149}
-------------------------

*See Also TLI and Folate.*

**Normal:**

249-733 ng/L (dog); 290-1500 ng/L (cat).

**Patient Preparation:**

Overnight fast.

**Collect:**

Whole blood, 4.0 mL (red-topped tube); separate serum from cells immediately.

**Submit:**

Serum, 2.0 mL.

**Interpretation:**

The test usually is performed in conjunction with TLI and serum folate. Decreased levels of cobalamin (vitamin B~12~) support the diagnosis of small intestinal mucosal disease, small intestinal bacterial overgrowth, and exocrine pancreatic insufficiency. There is no significance attached to levels above the reported reference range.

**Interference:**

Hemolysis; lipemia.

CORTISOL, RESTING (BASAL): See ACTH STIMULATION TEST {#cesec150}
----------------------------------------------------

*Not Generally Recommended.*

**Normal:**

0.5-6.0 μg/dL (dog); 0.5-5.0 μg/dL (cat)

Resting plasma cortisol in dogs is not routinely recommended because of the wide range of values in healthy animals. Although dogs with hyperadrenocorticism are expected to have increased values, reported values may still be within the limits of the reference range listed for normal dogs.

DEXAMETHASONE SUPPRESSION TEST, LOW-DOSE (LDDS TEST; DEXAMETHASONE SCREENING TEST) {#cesec151}
----------------------------------------------------------------------------------

**Normal:**

DogCatPre-test:0.5 to 6.0 μ g/dL0.5 to 5.0 g/dL4-hr Post-test:Usually \<1.0 μg/dLSame8-hr Post-test:Usually \< 1.0μ g/dLSame

**Patient Preparation:**

No prior treatment with corticosteroids for at least 5-7 days before testing.

**Collect:**

Heparinized whole blood, 1.0 mL to 2.0 mL at each collection (green-topped tube). NOTE: Do NOT collect blood in EDTA.

**Submit:**

Plasma, 0.5 mL minimum for each sample submitted; sample should be refrigerated if shipped. Sample is assayed for cortisol.

**Interpretation:**

This a screening test for hyperadrenocorticism in dogs and cats. Administration of dexamethasone decreases plasma cortisol to \<1.0 or 1.4 μg/dL (depending on the laboratory) within 2-3 hours in normal dogs. An 8-hr post-test sample \>1.4 μg/dL is consistent with Cushing\'s syndrome in dogs and cats with clinical signs (especially polydipsia) and supporting laboratory data and abdominal ultrasound. NOTE: LDDS does NOT differentiate between pituitary-dependent hyperadrenocorticism and adrenal tumor.

The 4-hr post-test sample is not interpreted as part of the screening test but is considered an aid in differentiating pituitary-dependent hyperadrenocorticism from adrenal-dependent disease. Demonstrating a transient cortisol suppression (4-hour post-tests sample) supports pituitary-dependent disease and rules out adrenal-dependent disease.

**Interference:**

Recent or concurrent corticosteroid administration. Anticonvulsant medications may adversely affect test results.

**Protocol:**

Collect pre-test sample of plasma; administer dexamethasone (either in sodium phosphate or polyethylene glycol) at **0.01 mg/kg IV** in dogs, or **0.1 mg/kg IV** in cats; then collect a 4-hr post-test plasma sample, followed by an 8-hr post-test plasma sample. Submit the three plasma samples. (NOTE the higher dose of dexamethasone used in cats vs. dogs.)

DEXAMETHASONE SUPPRESSION TEST, HIGH-DOSE (HDDS TEST) {#cesec152}
-----------------------------------------------------

**Normal:**

DogCatPre-test:0.5 to 6.0 μg/dLSame4-hr Post-test:Usually \<1.0 μg/dLSame8-hr Post-test:Usually \<1.0 μg/dLSame

**Patient Preparation:**

No prior treatment with corticosteroids for at least 5-7 days before to testing.

**Collect:**

Heparinized whole blood, 1.0 mL to 2.0 mL at each collection (green-topped tube). NOTE: Do NOT collect blood in EDTA.

**Submit:**

Plasma, 0.5 mL minimum for each sample submitted; sample should be refrigerated if shipped; sample is assayed for cortisol.

**Interpretation:**

The HDDS test is used in dogs with abnormal ACTH stimulation or LDDS test results to distinguish between pituitary-dependent disease and adrenal tumor. Administration of dexamethasone decreases plasma cortisol to \<1.0 or 1.4 μg/dL (depending on the laboratory) within 2-3 hours in normal dogs. Dogs with an adrenal tumor or pituitary-dependent hyperadrenocorticism are not expected to demonstrate suppression of cortisol following administration of dexamethasone at the dose prescribed.

NOTE: "Suppression" is defined as:Plasma cortisol concentration \<50% of baseline at 4 hours or at 8 hours following dexamethasone administration.

orPlasma cortisol concentration \<1.4 μg/dL at 4 hours or at 8 hours following dexamethasone administration.

**Interference:**

Recent or concurrent corticosteroid administration. Anticonvulsant medications may adversely affect test results.

**Protocol:**

Collect pre-test sample of plasma; administer dexamethasone (either in sodium phosphate or in polyethylene glycol) at **0.1 mg/kg IV** in dogs, or **1.0 mg/kg IV** in cats; then collect a 4-hour post-test plasma sample, followed by an 8-hour post-test plasma sample. Submit the three plasma samples. (NOTE the higher dose of dexamethasone used in cats vs. dogs.)

ESTRADIOL (BASELINE) {#cesec153}
--------------------

**Normal:**

Not normally detectable (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in a red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

This assay is not commonly requested for dogs and cats. Elevated levels have been used to detect testicular tumors and ovarian remnant syndrome. However, better tests are available.

**Interference:**

Variations in results occur with different methodologies used.

FOLATE: See also TLI AND COBALAMIN {#cesec154}
----------------------------------

**Normal:**

6.5-11.5 μg/L (dog); 9.7-21.6 μg/L (cat).

**Patient Preparation:**

Overnight fast.

**Collect:**

Whole blood, 4.0 mL (red-topped tube); separate serum from cells *immediately*.

**Submit:**

Serum, 2.0 mL.

**Interpretation:**

Assay usually is performed in conjunction with TLI and serum cobalamin. Elevated levels of folate support the diagnosis of small intestinal bacterial overgrowth in the upper small intestine. Values below the reference range support the diagnosis of proximal small intestinal disease.

**Interference:**

Hemolysis; lipemia.

FRUCTOSAMINE {#cesec155}
------------

**Normal:**

225-375 μmol/L (dog and cat).

NOTE: refer to laboratory reference range; ranges vary depending on methodology used.

**Patient Preparation:**

Fasted.

**Collect:**

Whole blood, 2.0 mL, in a red-topped tube (serum), lavender-topped tube (plasma in), or green-topped tube (plasma in heparin). CAUTION: sample must be non-hemolyzed.

**Submit:**

Serum or plasma, 1.0 mL.

**Interpretation:**

Test reflects glycemic levels over the preceding 1 to 3 weeks; it generally is used in assessing quality of glycemic control in patients with diabetes mellitus.

**Interference:**

Hemolysis; icterus.

GASTRIN {#cesec156}
-------

**Normal:**

Varies according to individual laboratory (dog); results not established for cat.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL; sample should be kept frozen until assayed.

**Interpretation:**

Test is not commonly performed. Levels will be elevated in patients with functional gastrinoma, pyloric obstruction, renal failure, and gastric ulcers. There is no significance associated with decreased values.

**Interference:**

Concurrent administration of H~2~ antagonist drugs (e.g., cimetidine).

GLUCAGON STIMULATION (IVGS TEST) {#cesec157}
--------------------------------

This is a complex test protocol to perform and yields results that are not generally reliable in distinguishing patients with type 1 diabetes from those with type 2 diabetes. It has been used to diagnose patients with insulin-secreting tumor. However, risk is associated with performing this test in patients with insulin-secreting tumor. Administration of glucagon will elevate serum glucose, which, in turn, promotes secretion of excessive amount of insulin; subsequent hypoglycemic crisis is a potential consequence.

GLUCOSE CURVE, 12-HOUR {#cesec158}
----------------------

**Normal:**

Glucose concentration ranges between 100 mg/dL and 250 mg/dL for the entire sampling period (dog and cat).

**Patient Preparation:**

Ideally, a venous catheter should be placed 1 hour before starting serial collections. Patient attitude during testing is important, because stressed or unusually aggressive animals may not be appropriate subjects for this test.

**Collect:**

Venous blood, approximately 1 mL per collection; plan on drawing as many as seven samples.

**Submit:**

Serum from each sample for routine glucose determination.

**Interpretation:**

This test is used to evaluate glucose levels in diabetic patients receiving insulin, particularly those that may experience recurrence of clinical signs as a result of under-treatment. Objectively, sufficient numbers of samples should be collected to establish a true nadir (lowest point) during the day. For example, if the nadir is \>450 mg/dL, each dose of insulin might be increased by 1 to 2 units. When increasing insulin dose, it is appropriate to increase the dose by the same units for each administration throughout the day.

**Interference:**

Stress. Also, use of portable glucose meters to measure serial glucose levels in individual patients tends to result in lower values than actually are occurring.

**Protocol:**

The patient is given the usual dose of insulin and fed at home in the morning. On arrival at the hospital, a short intravenous catheter is placed in a suitable vein and secured appropriately. Serial samples are collected at 2-hour intervals over a 10-12 hour period. At the conclusion of the sampling period, the patient is usually fed and given a second daily dose of insulin, as appropriate. Then you, and the patient, can go home.

GLUCOSE TOLERANCE TEST, INTRAVENOUS (IVGT TEST) {#cesec159}
-----------------------------------------------

*Not Generally Recommended*.

**Normal:**

By 60 minutes post-injection, serum insulin should be within 1 standard deviation of the baseline, and serum glucose should be within normal reference range for both dogs and cats.

**Patient Preparation:**

24-hour fast. Pre-placement of an intravenous catheter is recommended.

**Collect:**

Whole blood, 2.0 mL in a red-topped tube, *for each sample submitted*.

**Submit:**

Serum, 1.0 mL, for each sample submitted.

**Interpretation:**

Uncommonly performed, the IVGT test is an "insulin secretagogue test" used to distinguish type 1 diabetes from type 2 in cats. (NOTE: It is appropriate to consider all diabetic dogs as having type 1 \[insulin-dependent\] diabetes.) Patients with a mean serum insulin level \>15 μg/mL by 60 minutes following injection are likely to have type 2 (non--insulin-dependent) diabetes. However, in cats, results are inconsistent and rarely diagnostic---another reason why this is NOT a popular test.

**Interference:**

Hemolysis. Prolonged contact of serum with RBCs will cause a false decrease in glucose concentration. (NOTE: Do NOT use gray-topped tubes to collect samples.) The IVGT test can be adversely influenced by diet, certain drugs (steroids, insulin), stage of estrus, underlying illness or infection (sepsis), and stress.

**Protocol:** 1.Fast the patient overnight.2.Place an intravenous catheter.3.Collect venous blood in a red-topped tube. Submit 1.0 mL serum for a baseline glucose.4.Administer 0.5 g/kg of 50% glucose solution IV over 30 seconds.5.Collect approximately 2.0 mL of whole blood each: 1 minute, 5 minutes, 15 minutes, 25 minutes, 35 minutes, 45 minutes, 1 hour, and 2 hours following administration of glucose. (times may vary slightly depending on author and/or reference used).6.Submit 0.5-1.0 mL of serum for each sample. NOTE: Centrifuge and separate each serum sample as soon as practical after clot formation.

Each sample is submitted for *both* insulin and glucose determination.

GLUCOSE TOLERANCE TEST, ORAL (OGT TEST) {#cesec160}
---------------------------------------

*Not Generally Recommended.*

The OGT test, although commonly performed in humans, is rarely performed in dogs and cats because of the difficulty associated with reliably administering the required volume of glucose orally.

An oral glucose absorption test has previously been described in the literature as a means of assessing patients with malabsorptive gastrointestinal disorders. Today, considering that superior tests are available, this test is no longer recommended for the assessment of malassimilation in dogs and cats.

INSULIN {#cesec161}
-------

**Normal:**

5-20 μU/mL (dog and cat).

**Patient Preparation:**

Overnight fast.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Test is indicated for the diagnostic assessment of patients suspected of having an insulin-secreting tumor (e.g., insulinoma). If the patient has profound hypoglycemia at the time the test sample is collected, test results for insulin may be reported as normal. Simultaneous testing of serum glucose is recommended. Low glucose (\<60 mg/dL) and an insulin level \>20 μU/mL are consistent with insulin-secreting tumor.

**Interference:**

Hemolysis; blood collected in EDTA (plasma).

**Protocol:**

Most laboratories recommend that the patient\'s insulin level be determined in conjunction with blood glucose. Profound hypoglycemia may result in a normal insulin level being reported. A recent meal as well as several drugs can influence insulin concentrations.

PARATHYROID HORMONE (PTH) {#cesec162}
-------------------------

**Normal:**

2-13 pmol/L (dog and cat). Results vary among laboratories.

**Patient Preparation:**

12-hour fast.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum (FROZEN), 1.0 mL, in sterile plastic tube.

**Interpretation:**

PTH levels will be increased in patients with primary hyperparathyroidism, secondary renal or nutritional hyperparathyroidism, and other disorders causing hypocalcemia. No measurable PTH level is consistent with primary hypoparathyroidism. PTH testing should always include ionized calcium (iCa) assay.

**Interference:**

Hemolysis; thawing of sample for extended periods.

**Protocol:**

Serum should be separated from cells within 1 hour following collection; serum should be frozen and shipped on ice. Deliver to laboratory via overnight delivery. Keep frozen.

PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) {#cesec163}
-------------------------------------------

**Normal:**

Refer to laboratory reference range values (dog and cat).

**Patient Preparation:**

12-hour fast.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum (FROZEN), 1.0 mL, in sterile plastic tube.

**Interpretation:**

Interpretation of PTHrP entails simultaneous testing for calcium (or iCa) and PTH. PTHrP levels are low to undetectable in patients with primary hyperparathyroidism. Patients with hypercalcemia associated with lymphosarcoma or chronic renal insufficiency will have increased levels of PTHrP.

**Test Interference:**

Hemolysis; thawing of sample for extended periods.

**Protocol:**

Serum should be separated from cells within 1 hour following collection; serum should be frozen and shipped with ice in plastic tube. *Deliver to laboratory via overnight delivery. Keep frozen*.

T~3~ (3,5,3′-TRIIODOTHYRONINE) {#cesec164}
------------------------------

**Normal:**

0.8-1.5 mg/dL by radioimmunoassay (RIA) (dog); 0.8-1.5 ng/mL (by RIA) (cat).

NOTE: results will vary among different laboratories.

**Patient Preparation:**

None (patient should not be receiving exogenous thyroid hormone supplementation).

**Collect:**

Whole blood, 1-2 mL, in red-topped tube.

**Submit:**

Serum, 0.5 mL minimum. NOTE: Storage/shipment of samples in *plastic,* rather than glass, containers is recommended. Sample should be frozen and shipped with cold packs.

**Interpretation:**

T~3~ is a *poor indicator* of thyroid function and generally provides little reliable diagnostic information pertaining to thyroid-related disease; baseline T~3~ does NOT reliably distinguish between hypothyroid and euthyroid states. Test results for T~3~ include both free T~3~ (fT~3)~ and protein-bound T~3~. RIA is the preferred test method.

**Interference:**

Patients receiving exogenous thyroid supplementation can have positive or negative test interference, depending on the dose of drug administered and the time the last dose was given. T~3~ autoantibody, if present, may falsely lower test results. NOTE: Storage of serum or plasma *in glass* can cause a significant false increase in serum T~3~ concentration.

REVERSE T~3~ (RT~3;~ 3,3′, 5′-TRIIODOTHYRONINE) {#cesec165}
-----------------------------------------------

There are currently no established diagnostic guidelines associated with baseline reverse T~3~ values in dogs and cats.

T~3~ SUPPRESSION {#cesec166}
----------------

**Normal:**

Suppression of T~4~ to 1.5 μg/dL following seven doses of synthetic T~3~(in cats).

**Patient Preparation:**

None.

**Collect:**

Whole blood, 3.0 mL, in red-topped tube, for each sample (pre-test and post-test).

**Submit:**

Serum, 1.0 mL minimum for each sample.

**Interpretation:**

This test measures T~4~and T~3~ following sequential administration of seven doses of synthetic T~3;~ it may distinguish between euthyroid and slightly hyperthyroid cats. Hyperthyroid cats demonstrate minimal or no decrease in serum T~4~, which remains at 2.0 μg/dL or more. T~4~ values between 1.5 and 2.0 g/dL are nondiagnostic. T~3~values should increase in all cats (normal as well as hyperthyroid). NOTE: If T~3~ values do NOT increase, test results are considered invalid.

**Interference:**

Hemolysis; lipemia; icterus; blood collected in EDTA.

**Protocol:**

Pre-test sample is collected (to be submitted for T~3~ and T~4~).

FREE T~4~ (fT~4~) {#cesec167}
-----------------

**Normal:**

0.8-3.5 ng/dL (dog); 1.0-4.0 ng/dL (cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL minimum; freeze and store in plastic tubes rather than glass; ship samples with cold packs to arrive for analysis within 5 days of collection.

**Interpretation:**

Free T~4~ is used in preference to conventional T~4~ to confirm hypothyroidism in dogs and hyperthyroidism in cats. Results \<0.8 ng/dL (and *especially* \<0.5 ng/dL) are consistent with a diagnosis of hypothyroidism in dogs. As with conventional T~4~levels, free T~4~ levels in cats that exceed 4.0 ng/dL are consistent with the diagnosis of hyperthyroidism.

**Interference:**

Storing/shipping serum in glass container may alter test results; circulating thyroid autoantibody does NOT interfere with test results. Results determined by RIA alone may be significantly lower than those determined by the MED method. Severe illness may cause low fT~4~ values in dogs with normal thyroid function (sick, euthyroid). T~4~ autoantibody does NOT interfere with the assay for free T~4~.

TOTAL T~4~, (THYROXINE OR TETRAIODOTHYRONINE) {#cesec168}
---------------------------------------------

**Normal:**

1.5-3.5 μg/dL (dog); 1.0-4.0 μg/dL (cat).

NOTE: A point-of-care ELISA test kit for in-hospital assessment of T~4~is available. However, it is recommended that ELISA test results be confirmed by RIA.

**Patient Preparation:**

None (patient should not be receiving exogenous thyroid hormone supplementation).

**Collect:**

Whole blood, 1-2 mL, in red-topped tube.

**Submit:**

Serum, 0.5 mL minimum. NOTE: storage/shipment of samples in *plastic,* rather than glass, containers is recommended. Sample should be frozen and shipped with cold packs.

**Interpretation:**

T~4~ is produced within the thyroid gland, and therefore the total T~4~ is the preferred test of thyroid function. The test combines measurement of free T~4~ (fT~4~) plus protein-bound T~4~. Dogs with T~4~ levels \<2.0 μg/dL are likely to have hypothyroidism (if associated clinical signs are present); cats with T~4~ levels \>4.0 μg/dL are likely to have hyperthyroidism.

*Dogs:* Decreased values suggest hypothyroidism (dogs); however, dogs with underlying illness NOT related to abnormal thyroid function may still have abnormally decreased T~4~concentration (sick, euthyroid). A comprehensive physical examination and laboratory profile are indicated in establishing a diagnosis of hypothyroidism in dogs.

*Cats:* In middle-aged and old cats, hyperthyroidism becomes an important differential diagnosis when T~4~ levels exceed 4.0 μg/dL in the presence of clinical signs. Most cases are caused by a functional multinodular adenoma. Less than 5% of cases are associated with thyroid adenocarcinoma.

**Interference:**

Patients receiving exogenous thyroid supplementation can have positive or negative test interference, depending on the dose of drug administered and the time the last dose was given. Underlying illness and T~4~ autoantibody, if present, may falsely lower test results. NOTE: Storage of serum or plasma *in glass* can cause a significant false increase in serum T~4~ concentration.

THYROTROPIN, CANINE (THYROID-STIMULATING HORMONE \[TSH\]; BASELINE TSH) {#cesec169}
-----------------------------------------------------------------------

**Normal:**

Up to 0.6 ng/mL (dog); values not established for cats.

NOTE: Lower limits of normal (\~ 0.1 ng/mL) for methodologies used are below the sensitivity of the assay.

**Patient Preparation:**

None, if patient is not receiving exogenous thyroid hormone supplementation.

**Collect:**

Venous blood, 1-2 mL, in red-topped tube.

**Submit:**

Serum, 0.5 mL minimum. NOTE: Storage/shipment of samples in *plastic,* rather than in *glass*, containers is recommended. Sample should be frozen and shipped with cold packs.

**Interpretation:**

This is a reasonable test for the assessment of hypothyroidism in dogs; however, TSH fluctuations can produce normal results in 20% to 40% of hypothyroid dogs. TSH should not be interpreted without having same-sample results for T~4~ or fT~4~. A low T~4~ or fT~4~ and increased TSH in a dog are consistent with the diagnosis of hypothyroidism. Normal T~4~ or fT~4~ and TSH effectively rule out hypothyroidism. Clinical signs and a routine laboratory profile must be part of the diagnostic assessment of any patient suspected of having thyroid disease.

**Interference:**

The same interfering factors that influence T~4~ assays are likely to affect TSH.

THYROID-STIMULATING HORMONE, Canine: See THYROTROPIN, CANINE {#cesec170}
------------------------------------------------------------

 

THYROTROPIN RESPONSE (TSH RESPONSE TEST) {#cesec171}
----------------------------------------

*Not Generally Recommended.*

Initially believed to be useful in diagnosing hyperthyroidism, the TSH response test has been shown in subsequent studies to be limited in the ability of abnormal thyroid tissue to respond to stimulation. Other test limitations, including the removal of bovine TSH from the market, have resulted in the current recommendation against its use.

IMMUNOLOGY {#cesec172}
==========

ALLERGEN-SPECIFIC IGE ANTIBODY TEST (RADIOALLERGOSORBENT TEST \[RAST\]; ALLERGY SCREEN) {#cesec173}
---------------------------------------------------------------------------------------

**Normal:**

Refer to laboratory for interpretation of results reported.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube,

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

This in vitro assay is used to identify causative allergens in atopic animals. The RAST has also been suggested for evaluation of patients with suspected food-related hypersensitivity. At this time, results are inconclusive.

**Interference:**

Concurrent corticoid therapy.

ANTIBODY TITERS FOR INFECTIOUS DISEASE DIAGNOSIS: See INFECTIOUS DISEASE SEROLOGY and microbiology {#cesec174}
--------------------------------------------------------------------------------------------------

 

ANTINUCLEAR ANTIBODY (ANA) {#cesec175}
--------------------------

**Normal:**

Results are reported as a titer (ratio); refer to the laboratory reference range (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

This is an adjunctive (arguably the most important) test in the assessment of patients suspected of having systemic lupus erythematosus (SLE). Results must be interpreted after considering other underlying disorders in the individual patient. Low positive titers will be reported in patients having any of several disorders, including inflammatory disease, neoplasia, and infectious diseases. A high positive titer, in the presence of associated clinical and laboratory findings, supports a diagnosis of SLE.

**Interference:**

Concurrent illness or infection.

ANTIPLATELET ANTIBODY {#cesec176}
---------------------

No Commercially Available Test.

To date, a sensitive and specific test for the diagnosis of immune-mediated thrombocytopenia (ITP) by determination of antiplatelet antibody has not been developed. Generally, *extreme* thrombocytopenia (\<30,000 platelets/mm^3^) is managed with immunosuppressive doses of corticosteroids on the assumption that the condition is immune-mediated.

COOMBS TEST (DIRECT COOMBS TEST; DIRECT ANTIGLOBULIN TEST \[DAT\]) {#cesec177}
------------------------------------------------------------------

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Anticoagulated venous blood, 2.0 mL, in EDTA (lavender-topped tube).

**Submit:**

Entire sample.

**Interpretation:**

The Coombs test detects presence of antibody and/or complement on the surface of RBCs and supports the diagnosis of immune-mediated hemolytic anemia (IMHA). It is generally reported by degree of positivity: +1 to +4. Strength of the reaction does not predict severity of the disease or prognosis. A negative test result does not rule out the diagnosis of IMHA. The test is reported to be positive only 60% to 70% of the time.

**Interference:**

Concurrent steroid therapy; severe autoagglutination.

RHEUMATOID FACTOR, CANINE {#cesec178}
-------------------------

**Normal:**

Negative (dog); values not established for cats.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

This assay detects the presence of circulating autoantibody directed against IgG. It is an adjunctive test used in the diagnostic assessment of patients suspected of having rheumatoid arthritis or SLE. Results are reported as "positive" or "negative." A positive test result does not confirm a diagnosis of rheumatoid arthritis. Several other immune-mediated disorders, especially if chronic, can cause positive test results.

**Interference:**

Osteoarthritis; fibrositis; polyarteritis nodosa.

INFECTIOUS DISEASE SEROLOGY AND MICROBIOLOGY {#cesec179}
============================================

*ANAPLASMA PHAGOCYTOPHILA* ANTIBODY (FORMERLY *EHRLICHIA EQUI*) {#cesec180}
---------------------------------------------------------------

**Normal:**

Negative (dog)

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Limited studies are available about antibody responses to infection with *A. phagocytophil* a; refer to the laboratory test results for information on interpretation.

**Interference:**

Cross-reactivity with *A. platys* is expected.

*ASPERGILLUS* SPP. ANTIBODY TITER (NON-AVIAN) {#cesec181}
---------------------------------------------

*Not Generally Recommended.*

The high rate of false-positive and false-negative test results (depending on test methodology) limits the value of serology in establishing a diagnosis of aspergillosis in dogs without clinical signs.

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2-3 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL minimum.

**Interpretation:**

It is recommended to concurrently request *Penicillium* spp. titer. A positive antibody titer in a dog that is not responsive to empirical antibiotic therapy and with persistent nasal discharge, masseter muscle atrophy, and erosions of the nasal planum is highly suspect for aspergillosis.

**Interference:**

A positive test result may simply denote exposure.

*BABESIA* ANTIBODY TITER, CANINE {#cesec182}
--------------------------------

**Normal:**

*B. canis*, \<80; *B. gibsoni*, \<320.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2-3 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL minimum.

**Interpretation:**

Titers \>80 for *B. canis* or \>320 for *B. gibsoni* are consistent with the diagnosis of infection in patients with corresponding clinical symptoms.

**Interference:**

There can be considerable cross-reactivity between serologic assays for *B. canis* and *B. gibsoni.* Negative results in patients suspected of being infected should be followed with a convalescent sample 4 weeks following the initial test.

*BARTONELLA* SPP. (*BARTONELLA HENSELAE* TITER) {#cesec183}
-----------------------------------------------

**Normal:**

Negative (cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Different test methodologies are used commercially, including IFA (immunofluorescent assay), ELISA (enzyme-linked immunosorbent assay), and Western blot analysis. Although there is cross-reactivity with other *Bartonella* species, the test is reported to be relatively sensitive and specific for infection in cats. At issue, however, is whether all cats that test positive are, in fact, clinically ill and whether treatment is indicated on the basis of one positive test result. Results on positive cats may be reported as Serum, +1 to +4.

**Interference:**

None reported.

BLASTOMYCOSIS ANTIBODY TITER {#cesec184}
----------------------------

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL minimum.

**Interpretation:**

A positive serologic test in a dog with clinical signs consistent with blastomycosis does correlate with infection. Many cats with known blastomycosis infection, however, will have negative serologic results.

**Interference:**

None reported.

BLOOD CULTURE (BACTERIA) {#cesec185}
------------------------

**Normal:**

Negative at 10+ days following incubation (dog and cat).

**Patient Preparation:**

Ideally, sample should be collected while patient is febrile. The peripheral vein must be surgically prepared prior to venipuncture. Use at least two veins. Do not collect blood via a catheter.

**Collect:**

Venous blood, 6-10 mL, in a syringe (with no anticoagulant added).

**Submit:**

Transfer blood directly to a suitable (commercially prepared) vial containing a blood culture medium. NOTE: special media designed to remove certain antibiotics are available for patients that are concurrently receiving antibacterial therapy at the time of sample collection.

**Interpretation:**

The laboratory will report identification of any growth and minimum inhibitory concentration (MIC) susceptibility test results.

**Interference:**

Contaminating bacteria obtained during the collection process.

**Protocol:**

Samples from a separate vein, when feasible, should be collected. Generally, three samples are submitted from the same patient taken at approximately 1-hour blood intervals, collected by venipuncture (syringe and needle) from different sites.

*BORRELIA BURGDORFERI:* See LYME BORRELIOSIS {#cesec186}
--------------------------------------------

 

BRUCELLA CANIS ANTIBODY {#cesec187}
-----------------------

### Preliminary Assessment by RSAT OR TAT {#cesec188}

(RSAT = rapid slide agglutination test; TAT = tube agglutination test)

**Normal:**

Negative (dog).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Dogs with a negative test result are likely not to be infected. Follow-up testing is recommended for dogs with a negative test result but high likelihood of infection. Dogs with a positive test result should be retested by agar gel immunodiffusion (AGID) (see following entry) to confirm infection.

**Interference:**

Because of the nature of the screening tests, the frequency of false-positive test results can be high.

**Protocol:**

Both the RSAT and the TAT should be performed with 2-mercaptoethanol (2-ME) to eliminate interference caused by heterologous IgM (responsible for most false-positive reactions).

NOTE: optional testing by IFA is commercially available. Consider using IFA to compare with the RSAT and TAT.

### Confirmatory Test by AGID (Agar Gel Immunodiffusion) {#cesec189}

**Normal:**

Titers \<50 are considered negative (dog).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Titers \>200 are generally consistent with positive results on blood culture.

**Interference:**

None reported.

CANINE DISTEMPER ANTIBODY {#cesec190}
-------------------------

 

CEREBROSPINAL FLUID (CSF) (IgG or IgM) {#cesec191}
--------------------------------------

**Normal:**

Negative (refer to laboratory reference range).

**Patient Preparation:**

Fluid should be collected from the cisterna magna; sample is collected with the patient under general anesthesia and an endotracheal tube placed; sterile technique is required.

**Collect:**

CSF.

**Submit:**

CSF, 1.0 mL.

**Interpretation:**

The presence of any titer for canine distempter virus antibody (IgG or IgM) in CSF is consistent with infection, provided there is no contamination of the sample with blood or plasma. CSF titers should be assessed in conjunction with serum antibody titer.

**Interference:**

Blood or plasma contamination of sample during collection may cause false-positive results in vaccinated dogs. Vaccine-induced antibody is not expected to cross into CSF.

NOTE: when assessing individual patients for distemper antibody, various laboratory methods are used to perform serology. The virus neutralization (VN) test method for CDV antibody is recommended.

SERUM (IgG or IgM) {#cesec192}
------------------

**Normal:**

IgG (single sample titer is inconclusive). Uninfected dogs have no evidence of a rising titer when results of the acute and convalescent titers are compared. A single IgM titer will be negative. Vaccination will affect results. Refer to laboratory reference range.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL.

**Submit:**

Serum, 1.0 mL.

### Virus Neutralization (VN) Test {#cesec193}

**Normal:**

Vaccination will affect results. Refer to laboratory reference range.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Actual test results may vary from one laboratory to another. Individual laboratories will provide interpretation information.

NOTE: Serum virus neutralization is the preferred test to use when assessing antibody response subsequent to vaccination.

COCCIDIOIDOMYCOSIS ANTIBODY TITER (AGID) {#cesec194}
----------------------------------------

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Commercial laboratories may perform an initial screening test on samples. False positive rates on these tests may be high. Any patient having a positive test result on screening should be subjected to an antibody titer by AGID.

**Interference:**

Cross-reactivity in patients with histoplasmosis or blastomycosis can occur with all test methods used to detect *C. immitis* antibody.

CRYPTOCOCCAL ANTIGEN (SERUM OR CSF) {#cesec195}
-----------------------------------

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube; CSF, 0.5 mL.

**Submit:**

Serum, 1.0 mL; CSF, 0.5 mL.

**Interpretation:**

Any titer to *C. neoformans* is consistent with infection and justifies treatment. Antibody titers for cryptococcosis are not valid.

**Interference:**

None reported.

*EHRLICHIA CANIS* ANTIBODY {#cesec196}
--------------------------

**Normal:**

Refer to laboratory reference range (dog and cat).

A point-of-care test for in-hospital use in dogs will be negative in the non-exposed patient.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Interpretation varies among laboratories and methodologies used to detect antibody. The clinician must consider test results with clinical signs and results of routine laboratory profiles when making the decision to treat a patient with a positive titer. Dogs with confirmed infections may continue to have a positive antibody titer for *E. canis* for several months following recovery.

NOTE: Correlation between antibody titer and active infection is poor with *all available antibody tests* on the market today.

**Interference:**

None reported.

*EHRLICHIA EQUI* ANTIBODY: See *ANAPLASMA PHAGOCYTOPHILA* ANTIBODY {#cesec197}
------------------------------------------------------------------

 

*EHRLICHIA* SPP.: See POLYMERASE CHAIN REACTION (PCR) FOR TEST METHOD {#cesec198}
---------------------------------------------------------------------

 

FELINE CORONAVIRUS ANTIBODY (FeCoV Ab) {#cesec199}
--------------------------------------

*Inappropriately called the "FIP Ab test"; not generally recommended.*

Coronavirus titer is not a diagnostic test for feline infectious peritonitis (FIP). In fact, at this time there is no diagnostic test for FIP. The only value in submitting serum for a coronavirus titer is to identify cats that have a truly negative antibody titer (titered to zero). A negative antibody titer, although exceptionally rare among domestic cats, may denote no prior exposure to coronavirus (FIP).

EHRLICHIA spp (by Polymerase Chain Reaction \[PCR\]) {#cesec200}
----------------------------------------------------

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in EDTA (lavender-topped tube).

**Submit:**

Entire sample.

**Interpretation:**

Reported as positive or negative; positive samples should be subjected to further testing in order to confirm infection.

**Interference:**

PCR tests are subject to false-positive results because of minute traces of cross-reacting DNA in the sample.

FELINE INFECTIOUS ANEMIA: See *HAEMOBARTONELLA (MYCOPLASMA HAEMOFELIS)* {#cesec201}
-----------------------------------------------------------------------

 

FELINE LEUKEMIA VIRUS ANTIGEN (FeLV Ag; p27 TEST) {#cesec202}
-------------------------------------------------

NOTE: ALL commercial and in-hospital FeLV tests detect antigen, *not* antibody.

**Normal:**

Negative (denotes absence of virus).

**Patient Preparation:**

None.

**Collect:**

*IFA:* Whole blood, 1.0 mL, in EDTA (lavender-topped tube).

*ELISA:* Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

*IFA:* buffy coat smear or 1.0 mL anticoagulated whole blood collected in EDTA; NOTE: IFA is the preferred method for assessing bone marrow aspiration samples for FeLV Ag.

*ELISA:* Serum, 1.0 mL.

**Interpretation:**

Both the IFA and the ELISA detect the presence of the core protein p27.

*IFA:* a positive test result identifies the presence of FeLV cell--associated antigen (in WBCs and/or platelets) and defines "persistent infection," especially in cats with clinical and/or laboratory signs consistent with FeLV infection.

*ELISA:* a positive test result identifies the presence of soluble, circulating FeLV antigen; healthy cats with a positive test result should be retested 1 to 2 months later to reassess virus status OR be subjected to corroborative testing by IFA.

NOTE: The AAFP/AFM Task Force on Feline Retrovirus Testing stresses that healthy cats with positive test results may have false-positive test results (by either method). Corroborative testing is indicated using a different test method. A positive test result in a cat with clinical signs suggestive of chronic illness, lymphoid neoplasia, or significant hematologic abnormalities is highly indicative of infection. Negative test results are highly accurate.

**Interference:**

FeLV vaccination will not interfere with test results, regardless of test method used.

*IFA:* Thrombocytopenia and/or leukopenia may cause false-negative test results. Poor slide quality, eosinophilia, and hemolysis may influence ability to accurately read stained slides.

*ELISA:* Hemolysis.

NOTE: The AAFP/AFM Task Force on Feline Retrovirus Testing no longer stipulates that the IFA for FeLV Ag is the "confirmatory test" for cats with positive ELISA results. In fact, the ELISA is more sensitive than the IFA in detecting the presence of FeLV antigen.

FELINE IMMUNODEFICIENCY VIRUS ANTIBODY (FIV Ab) {#cesec203}
-----------------------------------------------

**Normal:**

Negative (negative test results indicate no prior FIV exposure).

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL each for IFA (or ELISA) and Western blot analysis.

**Interpretation:**

Cats with a positive test result by IFA (or ELISA) should be subjected to confirmatory testing by Western blot analysis.

**Interference:**

Any cat having received at least 1 inoculation with the FIV vaccine (killed, adjuvanted product) will produce interfering antibody that is detected by all commercially available FIV Ab tests (IFA, ELISA, Western blot analysis). False-positive test results are expected to persist for at least 1 year following vaccination. Currently, there is NO test that will reliably and consistently distinguish between infected and vaccinated cats, including polymerase chain reaction (PCR). Also, kittens that have nursed from vaccinated queens are expected to have a false-positive test result for FIV Antibody associated with maternally derived antibody. Duration of the false-positive results is unknown.

Kittens less than 6 months of age are expected to have maternally derived antibody if the queen is infected and may have a false positive test result when tested by IFA or ELISA. Subsequent testing of positive kittens at 6 months of age or older is indicated to determine true infection status.

NOTE: The AAFP/AFM Task Force on Feline Retrovirus Testing stresses that healthy cats with a positive test result (by IFA or ELISA) may have false-positive test results, especially in populations in which the prevalence of infection is low. Confirmatory testing is indicated using the Western blot analysis. Negative test results are highly accurate.

*GIARDIA* ANTIGEN {#cesec204}
-----------------

**Normal:**

Negative for antigen (dog and cat).

**Patient Preparation:**

None.

**Collect:**

2 to 5 grams of fresh feces.

**Submit:**

Entire sample in a sterile container; sample can be stored for 24 hours at 2° to 8° C. Frozen feces may be stored for slightly longer periods.

**Interpretation:**

Test results are reported as either positive or negative for antigen; positive test results are expected in dogs or cats during active cyst and trophozoite shedding. The zoonotic potential of canine and feline giardiasis is controversial.

**Interference:**

Extended or improper storage of the sample could result in false-negative results.

HEARTWORM ANTIBODY, FELINE {#cesec205}
--------------------------

NOTE: See also Heartworm Antigen, Feline.

**Normal:**

Negative.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 1.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Test results should be interpreted in conjunction with a heartworm antigen test performed on the same sample. Because diagnostic confirmation of heartworm infection in cats is problematic (for several reasons), serologic test results must be considered in light of other laboratory and radiographic assessments.

A negative heartworm antibody (HW-Ab) test result suggests that there has been no exposure to *Dirofilaria immitis.* A negative result typically is used to rule out feline heartworm infection.

A positive HW-Ab test result only supports prior exposure. It does NOT confirm infection. Cats that are positive for HW-Ab should be subsequently tested for heartworm antigen (see below).

**Interference:**

Marked hemolysis or lipemia.

HEARTWORM ANTIGEN, FELINE {#cesec206}
-------------------------

NOTE: See also Heartworm Antibody, Feline.

**Normal:**

Negative.

**Patient Preparation:**

None

**Collect:**

Whole blood, 2.0 mL, in a red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Test results should be interpreted in conjunction with a heartworm antibody test performed on the same sample. Because diagnostic confirmation of heartworm infection in cats is problematic (for several reasons), serologic test results must be considered in light of other laboratory and radiographic assessments.

A negative heartworm antigen (HW-Ag) test result is not diagnostically useful; heartworm infection is still possible. A positive HW-Ag test result is highly specific; infection is likely.

Interference:

Marked hemolysis may cause a false-positive test result. A cat with male heartworm infection only will not have a positive result. Low worm burdens (common) may result in false-negative test results.

HEARTWORM ANTIGEN, CANINE {#cesec207}
-------------------------

**Normal:**

Negative.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

A negative (HW-Ag) test result implies no infection; a positive HW-Ag test result strongly supports active infection.

**Interference:**

Marked hemolysis may cause a false-positive test result. A dog with a small worm burden may have a false-negative test result. NOTE: the canine HW-Ag test may remain positive for up to 16 weeks following adulticide therapy.

*HAEMOBARTONELLA* (FELINE INFECTIOUS ANEMIA; *MYCOPLASMA HAEMOFELIS, M. HAEMOMINUTUM*) {#cesec208}
--------------------------------------------------------------------------------------

**Normal:**

Negative.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 1.0 mL in EDTA (lavender-topped tube).

**Submit:**

Submit entire sample; see Polymerase Chain Reaction (PCR) for test method.

**Interpretation:**

A positive test result is supportive of the diagnosis of infection; a negative test result implies no exposure.

**Interference:**

Sample contamination; improper handing; extended storage times. Samples are stable for 48 hours if refrigerated at 2° to 8° C.

LEPTOSPIROSIS ANTIBODY TITER {#cesec209}
----------------------------

**Normal:**

Negative.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 4.0 mL, in red-topped tube.

**Submit:**

Serum, 2.0 mL

**Interpretation:**

Laboratories in the U.S. provide titers for some or all of the following serovars: *L. canicola, L. icterohemorrhagica, L. grippotyphosa, L. pomona, L. bratislava, L. hardjo, and L. autumnalis.* A positive test result may indicate infection (high titers in the presence of clinical signs), prior exposure, or recent vaccination. A negative titer indicates no recent exposure. CAUTION: interpretation of Ab titer results for leptospirosis on the basis of *a single serum sample* in previously vaccinated dogs is difficult and may not be indicative of infection. A single positive antibody titer for *any* serovar in a healthy, recently vaccinated dog is not diagnostic for infection. Documentation of a rising titer, based on test results of two samples 3 to 4 weeks apart, is strongly recommended to establish a diagnosis.

**Interference:**

Recent vaccination (regardless of the titer and the number of vaccine serovars administered).

NOTE: when submitting samples for leptospirosis serology, it is important to provide information regarding date of last vaccination (if known), key clinical signs, and known laboratory abnormalities.

LYME BORRELIOSIS (*BORRELIA BURGDORFERI*) {#cesec210}
-----------------------------------------

### C6 Peptide Ab by ELISA (SNAP 3Dx Test) {#cesec211}

**Normal:**

Negative (dog).

**Patient Preparation:**

None.

**Collect:**

Venous blood, 1.0 mL, in a syringe or red-topped tube (for submission).

**Submit:**

Use collected sample for the point-of-care (SNAP) test. Submit a minimum of 0.5 mL of serum if test is being sent to a commercial laboratory.

**Interpretation:**

A positive test result denotes exposure to *B. burgdorferi*; the presence of C6 antibody has a high correlation with infection. Infection is not always associated with clinical signs. The decision to treat or not to treat a healthy dog with a positive test result is based on the clinician\'s assessment of the individual patient and supporting laboratory data.

NOTE: Occasionally, a dog will have a negative test result subsequent to treatment. However, this an inconsistent finding. Use the quantitative C6 antibody test to monitor response to treatment.

**Interference:**

None; prior vaccination (regardless of vaccine used) will NOT cause false-positive test results.

**Protocol:**

Sample may be submitted to a commercial laboratory or can be rapidly assessed in the hospital as a point-of care (SNAP) test; follow manufacturer\'s procedure outline.

### Quantitative C6 Antibody Test {#cesec212}

**Normal:**

Usually \<30 antibody units (dog); refer to the laboratory reference range.

**Patient Preparation:**

None.

**Collect:**

Venous blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Patients with antibody levels \>30 antibody units by the quantitative assay may be at risk of developing clinical disease. Patients with an initial positive test that undergo treatment for Lyme borreliosis infection can be monitored for response (decline in antibody level) to treatment over time.

**Interference:**

None; prior vaccination (regardless of vaccine used) will NOT cause false-positive test results.

**Protocol:**

The quantitative test generally is indicated for patients that have (1) tested *positive* by the SNAP test and/or (2) are undergoing treatment for Lyme borreliosis.

### *Borrelia burgdorferi* Antibody (IFA and Western Blot Analysis) {#cesec213}

*Not Generally Recommended*

The sensitivity and specificity data on C6 antibody support the recommendation that routine laboratory testing of patients suspected of having Lyme borreliosis be based on either the C6 antibody (SNAP test) or the quantitative C6 antibody test.

### Indirect Fluorescent Antibody (IFA) {#cesec214}

**Normal:**

Values vary among laboratories. A negative titer is normal and indicates no exposure to *B. burgdorferi* or recent vaccination.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Titers performed by IFA may not distinguish between vaccinated and infected dogs. Lyme borreliosis titers performed by IFA are only indicated in dogs that have NOT been vaccinated against Lyme disease. Lyme borreliosis vaccination can result in a positive titer. Dogs with a positive test result should be subjected to either the Western blot analysis or the quantitative C6 antibody test (preferred).

**Interference:**

Prior vaccination against Lyme disease can result in a positive test result.

### Western Blot Analysis {#cesec215}

**Normal:**

Values vary among laboratories. A negative test result is normal and indicates NO exposure to *B. burgdorferi*.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Titers may distinguish between vaccinated and infected dogs. Western blot analysis is indicated for dogs that have a positive IFA titer, as an alternative test.

**Interference:**

Prior vaccination with a whole-cell, killed *B. burgdorferi* vaccine may complicate interpretation of the Western blot analysis.

RABIES TITER (BY RFFIT) {#cesec216}
-----------------------

RFFIT = rapid fluorescent focus inhibition test.

**Normal:**

*Dog and cat:* A titer of 0.5 IU/mL or higher is usually required for animals exported to most rabies-free areas. NOTE: it may to necessary to contact individual countries for current import requirements prior to shipping animals.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 4.0 mL, in red-topped tube.

**Submit:**

Serum, 2.0 mL (minimum is 500 μL), in a leak-proof container (e.g., with screw-on cap). Place sample container should be placed inside a second container with gel packs or dry ice. Overnight shipping is recommended.

**Interpretation:**

As stipulated by the laboratory. NOTE: Values for a "protective titer" in animals have not been established.

**Interference:**

Gross hemolysis; lipemia; samples other than serum (e.g., plasma is NOT acceptable). **NOTE:** Other causes for sample to be rejected include insufficient quantity of serum, bacterial contamination of sample, and unlabeled sample.

**Protocol:**

Samples may be sent to: Rabies Laboratory/RFFIT, Mosier Hall, Kansas State University, 1800 Denison Avenue, Manhattan, KS 66506-5600 (Tel. 785-532-4483).

NOTE: For samples sent to Kansas State University:1.All specimen tubes must be labeled with the patient\'s name and/or identification number. Samples submitted without labels will not be accepted.2.All samples must have an accompanying RFFIT submission form.3.All animals being tested for export must have a microchip number (or tattoo) included.

Forms may be downloaded from the KSU Rabies Laboratory website: [www.vet.ksu.edu/rabies](http://www.vet.ksu.edu/rabies){#interref1}

ROCKY MOUNTAIN SPOTTED FEVER (RMSF) {#cesec217}
-----------------------------------

**Normal:**

Negative (dog and cat).

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

Generally, two samples are recommended ("acute" and "convalescent"), obtained 2 to 3 weeks apart. Titers reported vary among laboratories. The laboratory performing the titer will provide recommendations for interpreting results.

**Interference:**

None.

TOXOPLASMOSIS TITERS (IgG AND IgM) {#cesec218}
----------------------------------

**Normal:**

See Interpretation.

**Patient Preparation:**

None.

**Collect:**

Whole blood, 2.0 mL, in red-topped tube.

**Submit:**

Serum, 1.0 mL.

**Interpretation:**

A positive titer denotes exposure, not active infection. IgG and IgM titers typically are reported individually. A titer \>1:256 for IgM is consistent with active infection in patients with clinical signs (e.g., pneumonia in cats, myositis in dogs). It is recommended that two samples for IgG titer be submitted; samples should be collected 2 to 3 weeks apart. A fourfold or greater rise in titer within 2 to 3 weeks is supportive of the diagnosis of active infection. Cats seropositive on a single titer are unlikely to be shedding oocysts.

**Interference:**

Hemolysis; lipemia.

VACCINE TITERS: SEE LISTING UNDER SPECIFIC PATHOGEN {#cesec219}
---------------------------------------------------

Laboratories providing vaccine titers typically limit these services to canine parvovirus, canine distemper, and feline panleukopenia. A limited number of laboratories offer titers for feline herpesvirus-1 and feline calicivirus.

**Note:** Several university and commercial laboratories now provide antibody titers for selected canine and feline viruses as a means of assessing immunity to prior vaccination.

**Note:** National laboratory standards for determining serum antibody titers against these pathogens have not been established. Because methods for performing titers vary among laboratories, titer results and ranges also can vary dramatically.It is recommended that samples be analyzed by laboratories using the virus neutralization test (for canine distemper) and hemagglutination inhibition (for canine parvovirus and feline panleukopenia).

**Note:** A "positive" antibody titer usually will equate with "PROTECTIVE IMMUNITY"A "negative" antibody titer does NOT necessarily equate to "SUSCEPTIBILITY"

URINE {#cesec220}
=====

A red-topped tube is the preferred collection tube for urinalysis. A Copan swab can be used for urine culture, but this precludes quantitation of bacteria, if present. Urine for culture is best collected by cystocentesis and transported with a cold pack to prevent bacterial overgrowth.

CORTISOL, URINE. SEE URINE CORTISOL:CREATININE RATIO (UC:CR; URINARY C:C RATIO) {#cesec221}
-------------------------------------------------------------------------------

 

MICROALBUMINURIA TEST (EARLY RENAL DISEASE (ERD) IN-HOSPITAL TEST KIT) {#cesec222}
----------------------------------------------------------------------

**Normal:**

Negative test strip indication (dog and cat).

**Patient Preparation:**

None.

**Collect:**

2-mL (minimum) aliquot of urine in a clean container.

**Submit:**

Same.

**Interpretation:**

Test strip indicator grades the approximate degree of microalbuminuria. The manufacturer of the test kit provides recommendations for interpreting test results. However, it should be noted that a positive test result in clinically normal dogs is NOT known to be predictive of impending renal disease. In various studies, it has been shown that a significant percentage of healthy dogs and certain breeds (soft-coated Wheaten Terriers) will have positive test results. Until more information is available about the clinical utility of this test, its use should be restricted to monitoring urine protein loss in patients with known or suspected glomerular disease.

**Interference:**

Blood contamination of urine sample.

URINE CORTISOL:CREATININE RATIO (UC:CR, URINARY C:C RATIO) {#cesec223}
----------------------------------------------------------

**Normal:**

Varies according to individual laboratory and test methodology used (dog and cat).

**Patient Preparation:**

Owner should collect urine at home on the day (morning is preferable) that the test is submitted, thereby reducing stress-induced artifact.

**Collect:**

3.0- to 5.0-mL aliquot of pooled urine in a sterile container.

**Submit:**

Same; sample should be refrigerated during transport to the laboratory.

**Interpretation:**

The UC:CR is reported to have high sensitivity (negative predictive value) and therefore has been recommended *to rule out the diagnosis of hyperadrenocorticism in dogs*.

Controversy exists regarding the diagnostic value of the UC:CR to diagnose canine Cushing\'s syndrome. Reference values for the cat are not reported. The test currently is NOT recommended as a single diagnostic test. In SERIAL UC:CR studies performed in hyperthyroid cats, elevated ratios were observed; successful treatment (medical and surgical) did result in a significant decrease in UC:CR in cats.

**Interference:**

The effect of urine collected from hospitalized dogs (stress) vs. urine collected from dogs at home remains an arguable variable. Owners should be advised to collect urine at home on the scheduled day of examination/testing.

**Protocol:**

Instruct the owner to collect urine in a single, clean container over 2 consecutive hours on the same day that the urine sample is to be submitted to the laboratory. A 3.0- to 5.0-mL aliquot of pooled urine is submitted for analysis. NOTE: Not all commercial laboratories offer this test. Check before submitting.

URINE PROTEIN-CREATININE RATIO (UPCr; P:Cr; UPC) {#cesec224}
------------------------------------------------

**Normal:**

Ratio \<0.3 (dog); ratio \<0.6 (cat).

**Patient Preparation:**

None.

**Collect:**

2- to 3-mL aliquot of randomly collected urine in a clean container.

**Submit:**

Same.

**Interpretation:**

UP:Cr titer \>1.0 is consistent with the diagnosis of pathologic proteinuria. The ratio does not confirm the source of the protein loss. However, in patients with consistent hypoalbuminemia and significantly elevated urine P:Cr, loss of protein through the glomerulus is likely (e.g., glomerulonephritis).

**Interference:**

Blood contamination (cystitis, cystocentesis).

NOTE: Reference Range values listed throughout this section are for general reference *only.* Test results from individual patients *must be compared to the Reference Range Values* for the laboratory that performs the test.

Vacutainer® is the registered trademark of Becton, Dickenson and Company (B-D).

Ethylene Glycol Test Kit, PRN Pharmacal Inc., Pensacola, Fla.
